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ABSTRACT 
 Swerilactones and related natural products were isolated from the plant Swertia 
mileensis and related species from the Gentianacea family. All members have shown 
moderate bioactivity in a hepatitis B virus assay. Despite their appealing framework and 
bioactivity, to date no syntheses of these compounds have been reported in the literature. 
All members of the natural products family display a polycyclic framework, 
containing lactone-pyran fused bicyclic subunits, and are heavily oxygenated. En route to 
swerilactones A and B, featuring a complex pentacyclic (6/6/6/6) ring system, the 
successful syntheses of two key building blocks for studies of a biomimetic [4+2] 
cycloaddition have been accomplished. The challenges associated with the design of a 
novel synthesis of a 2H-pyran diene are presented and ultimately relied on a Saucy-Marbet 
rearrangement of a propargyl vinyl ether. Reactivity studies for the 2H-pyran have shown 
thermal normal demand and photoinduced, radical cation [4+2] cycloadditions are Diels-
Alder modes of choice, whereas inverse demand pathways were unproductive.  
Synthetic routes to obtain carboxylate and various enol ether substituted 
dienophilic lactones are also outlined. They relied on a unified strategy, comprised of the 
 
 
ix 
rapid assembly of a β-brominated sorbate derivative via cross-couplings and final oxa-6π 
electrocyclization as an original ring closure strategy. Our attempts at coupling the 2H-
pyran intermediate with the dienophilic lactones to access the core structure of 
swerilactones A and B, leveraging our preliminary reactivity studies are presented in 
detail. In addition, alternatives strategies to assemble the core structures of swerilactones 
A and B are described, along with our efforts (and potential routes) toward related 
members of this family of natural products. 
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CHAPTER 1                                                                                
 2H-Pyrans: Properties, Synthesis and Use in Natural Product Synthesis 
 
1.1 Introduction to 2H-Pyrans: Oxa-6π Electrocyclization Equilibrium 
Properties 
2H-Pyrans (pyrans saturated at the C2 position) are heterocyclic compounds 
existing in a mixture with oxatriene via equilibrium through an oxa-6π electrocyclization 
(called dienal if R=H and dienone if R≠H, Figure 1). This type of electrocyclization 
promotes valence isomerism, since both structures are constitutional isomers 
interconverting through a pericyclic reaction. This process is thermo-neutral and its low 
activation barrier renders the rearrangement easily reversible. 
Figure 1.1 2H-Pyran/Oxatriene Equilibrium 
 
 
The first example of an isolated 2H-pyran was described by Büchi and coworkers 
in 1957.1 Irradiation of an ethanolic solution of E-β-ionone 1 with a mercury lamp 
promoted E/Z isomerization of the alkene to form Z-β-ionone 2 in situ (Scheme 1.1). 
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Scheme 1.1 Photoinduced Isomerism of Trans-β-ionone 
 
 
This compound further underwent oxa-6π electrocyclization to 2H-pyran 3, a 
structure which was deduced through IR analysis and successful reduction of 3.1 Marvell 
and coworkers2 unambiguously determined the structure of 2H-pyran 3 by 1H NMR 
(Scheme 1.2). Interestingly, analysis of the 1H NMR spectra indicated an additional minor 
compound was present, but the presumed impurity could not be separated from 3. By 
increasing the temperature in the NMR sample, it was shown that the impurity’s content 
increased as well, and upon cooling, the spectra reverted back to its original content. 
Repeating this experiment through several cycles yielded no decomposition. This was 
attributed to the equilibrium between 3 and Z-β-ionone 2 which is temperature dependent, 
shifting from a 1:4 ratio (2:3) at 54 ˚C to a 1:1.5 ratio (2:3) at 113 ˚C.  
Scheme 1.2 Spectral Assignment of 2H-pyran 3 and its valence isomer 2 
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Aside from this example, systematic studies regarding the valence isomerism 
property are few, but give general trends.3–7 The equilibrium direction, as measured by 1H 
NMR, depends on several factors: 1) system electronics/sterics, 2) solvent polarity, and 3) 
temperature. The substitution pattern of the 2H-pyran scaffold generally has a significant 
influence on the valence isomerism. Steric bulk, especially with disubstitution at C2, favors 
the pyran form (Scheme 1.3, (A) vs (B), and (C) vs (D)). This is due to steric crowding in 
the dienone form, which forces the structure out of planarity, decreases the π system 
delocalization efficiency and destabilizes the dienone form. Electronics can have different 
effects, increasing the proportion of the dienone form to favor π-system conjugation 
((Scheme 1.3, (E)). With electron withdrawing substituents (preferentially at the C5 
position),8 the equilibrium shifts in favor of the corresponding 2H-pyran valence isomer 
((Scheme 1.3, (F)).9 
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Scheme 1.3 Isomerism Dependence on Steric and Electronic Factors 
 
 
Parameters such as temperature and solvent also impact the isomerism: higher 
temperature typically increases the proportion of the less stable Z-β-ionone.2 In polar 
aprotic solvents, the equilibrium is shifted in favor of the dienone form, potentially due to 
dipole minimization effects.5 
In terms of frontier molecular orbital analysis, the valence isomerism can be seen 
as a dynamic 6π/ring opening equilibrium. According to the Woodward-Hoffman rules for 
electrocyclizations, two disrotatory modes are at play (clockwise and counter-clockwise) 
and are responsible for the racemic production of the pyran valence isomer (Figure 1.2 
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(A)). The pyran isomer, in return, may display a preference during retro-6π for inward or 
outward opening (Figure 1.2 (B)). 
Figure 1.2 Valence Isomerism: Frontier Molecular Orbital Analysis and Experimental Controls 
 
This torquoselective behavior would induce potential alkene isomerization. 
Similarly to the torquoselectivity observed in retro-4π,10 electronic factors in retro-6π 
prevail over sterics, although their effect is less pronounced.11 In the case of R being an 
electron donor (its p orbital being occupied) the transition state would be destabilized by 
the pdonor-σ orbital interaction, forcing the R group to move outward (Figure 1.2 (C), left 
side). Alternatively, when R is an electron acceptor, the vacant p orbital would stabilize the 
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transition state through a favored pacceptor-σ orbital overlap (Figure 1.2 (C), right side). An 
interesting example showcasing this selectivity was investigated by the Porco group.12 
Having synthesized both E and Z version of the alkenyl side chain of a dienal 
(Figure 1.2 (D)), the outcome of the valence isomerism and the isomeric distribution 
diverged. Starting from the stereodefined E-alkene, an equilibrium between the two 
isomers was observed, favoring the closed form (9:1 ratio of pyran:dienal). In the event 
where the Z-alkene isomer was prepared, a distribution between the three products took 
place: the pyran equilibrated to the E-and Z-alkene dienal in a ratio of 8:1:1 respectively. 
This result is indicative of a higher energy barrier associated with inward rotation of the 
methyl group vs. outward opening. Calculations supported a relative difference in 
activation energy (ΔΔG≠) of 4 kcal/mol, favoring the opening to the E alkene.13 
Despite the equilibrium dependence on several innate factors, the direction of the 
valence isomerism can be temporarily perturbed if the oxygen of the 2H-pyran is in close 
proximity to another electronegative atom. Cases have been reported where chelating 
metals were able to shift the valence isomerism toward the ring-opened oxatriene.  
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Scheme 1.4 6π-Equilibrium Shift by Lewis Acid 
 
 
Employing equimolar equivalents of zinc(II), 2H-pyran 4 (which normally resides in its 
closed form) was fully opened to chelated form 514 which benefits from a long-range 
binding of Zn2+ with the carboxylic acid side chain and the electronic delocalization from 
the adjacent Nsp3 (Scheme 1.4, (A)). Another related example was achieved by Trauner and 
coworkers15 using Ti(IV) (Scheme 1.4, (B)). After acidic workup of the presumed titanium 
chelate of 6, the dienone system 7 is isolated and slowly reversed back via 6π 
electrocyclization to the starting pyran structure 6. 
 
1.2 Synthetic Methods to access 2H-Pyrans 
2H-Pyrans, though a prevalent structure in bioactive compounds, remain a challenging 
target synthetically. Of note, most α-pyrans are unstable to prolonged storage at ambient 
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temperature, decomposing in air and with potential to self-dimerize. Multiple methods to 
access 2H-pyrans depending on the substitution pattern have been developed; one would 
need to assess each method’s limitation when synthesizing a given α-pyran structure. Due 
to the valence isomerism inherent to α-pyrans, most methodologies target the opened 
oxatriene form, which may then undergo 6π-electrocyclization to 2H-pyrans. 
1.2.1 Metal Mediated [2+2+2] Cycloisomerization of Diynes and Carbonyls 
 Expanding upon the large body of work targeting diyne-alkene [2+2+2] 
cyclizations and motivated by the access to heterocyclic framework, several groups have 
successfully developed formal cycloadditions of diynes and carbonyls. A general scheme 
and mechanism for this type of transformation is outlined in Scheme 1.5. First, 
cycloisomerization produces a metallacycle 8, which then undergoes CO insertion to create 
7-membered-metallocycle 9. Reductive elimination affords the desired 2H-pyran structure 
10 (which may undergo valence isomerism to oxatriene 11). 
Scheme 1.5 Metal-Mediated Diyne-Carbonyls [2+2+2] 
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 A method directly targeting 2H-pyrans in their closed form was pioneered by the 
group of Tsuda in 1988.16 Using Ni(0) as a catalyst and tertiary phosphines as ligands, the 
investigators were able to promote the cycloaddition of alkyl-substituted, tethered diynes 
with aldehydes (Scheme 1.6). Terminal alkynes were not well tolerated in this 
methodology.  
Scheme 1.6 Tsuda’s Ni(0)-Catalyzed Cycloaddition of Diynes and Aldehydes 
 
 
Subsequently, Vollhardt and coworkers reported a similar transformation, mediated 
by stoichiometric cobalt,17 in neat acetone as a carbonyl source and a small number of 
terminal alkynes, expanding the scope of the reaction. In 2005, this chemistry was 
systematically studied by several investigators, including the Louie, Trost, Shibata, and 
Tanaka groups. The Louie group applied a Ni(0)/NHC catalytic system to promote 
cyclizations of alkyl substituted diynes with aldehydes and unactivated carbonyls (Scheme 
1.7).18,19 
Scheme 1.7 Louie’s Ni(0)/NHC-Catalyzed Cycloaddition of Diynes and Aldehydes 
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The Trost group used an alternative version, with a tethered bis-propargyl alcohol 
and cationic Ru(I) (Scheme 1.8).20,21  
Scheme 1.8 Ruthenium-Catalyzed Intramolecular Cycloisomerization of Propargyl Alkynes by Trost 
 
 
This reaction is proposed to follow a mechanism (Scheme 1.8) involving a 
cycloisomerization step of the tethered diyne to form metallacycle 12, followed by loss of 
water which forms the Ru2+ complex 13. Trapping by water affords complex 14 and 
subsequent hydride shift generates a ruthenium hydride species 15 which is poised for final 
reductive elimination thereby affording the oxatriene/α-pyran 16. 
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More recently, the Niggeman group demonstrated a similar cycloisomerization of 
tethered diynol with a cooperative Ca2+/CSA catalytic system.22 The proposed mechanism 
does not involve formation of a metallacycle, but is based on elimination of the hydroxyl 
mediated by Ca2+/CSA to afford the allenyl cation 17 (Scheme 1.9). Upon nucleophilic 
trapping by the neighboring alkyne (intermediate 17) and addition of water to the resulting 
vinyl cation (intermediate 18), the allenyl-enol 19 undergoes 1,5-H shift to afford the 
dienone structure. 
Scheme 1.9 Cycloisomerization of Diynols via Cooperative Ca2+/CSA System 
 
 
The groups of Tanaka23,24 and Shibata25 reported a cationic Rh(I)/BINAP system 
able to promote the [2+2+2] cyclization of diynes with activated and unactived ketones. A 
simple racemic BINAP was used as ligand by Shibata with ketoesters and diynes (Scheme 
1.10 (A)), and a modified H8-BINAP extended the scope to ketoesters and ketones 
(Scheme 1.10 (B)). 
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Scheme 1.10 Shibata’s and Tanaka’s Rh/BINAP Catalyzed Cyclization of Diynes and Ketoesters 
 
 
Future development for this type of methodology should be focused on increasing 
the scope of the reaction to access larger bicyclic systems, and better functional group 
tolerance as ketone or ester linked diynes are not broadly effective in this transformation.  
1.2.2 2H-Pyrans via Formal [3+3] Cycloaddition 
 One of the most common strategies toward α-pyrans relies on a formal [3+3] 
cycloaddition proceeding through an overall Knoevenagel condensation of 1,3-dicarbonyls 
with acrylate derivatives (Scheme 1.11). First, an aldol reaction occurs between the enol 
moiety of the 1,3-dicarbonyl and the α,β-unsaturated aldehyde. Water elimination leads to 
an oxatriene framework, undergoing valence isomerism with its 2H-pyran form.  
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Scheme 1.11 Formal [3+3] Strategy to 2H-Pyrans 
 
 
Several catalysis modes have been successfully applied to this reaction including 
iminium,26–30 Lewis acid,31,32 Brønsted acid,33 and Lewis base catalysts.34 Inspired by 
previous reports,35–37 Hsung and coworkers have reported coupling of iminium salts 
derived from acrylates to pyrone derivatives (Scheme 1.12) which had been shown to 
proceed in poor yields.38 Using a preformed piperidinium salt derived from α,β-unsaturated 
aldehydes (8) and further reaction with 4-hydroxypyrones 9, the investigators were able to 
synthesize bicyclic 2H-pyran products 10.26,27 This methodology was found to be efficient 
with cyclic unsaturated aldehydes, and was further applied to Meldrum’s acid derivatives28 
and 4-hydroxycoumarins as enol nucleophiles.29 
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Scheme 1.12 Iminium-Catalyzed Cycloaddition of Pyrones with α,β-Unsaturated Aldehydes 
  
 
An interesting application of the latter methodology en route to cyclopenta[b]furans 
was developed by Mischne and coworkers.30 An elegant one-pot process was designed 
(Scheme 1.13) wherein dimedone 11 was reacted with dienal 12 in the presence of ethylene 
diammonium diacetate, forming a transient pyran 13. This intermediate, upon ring opening, 
slowly undergoes an E/Z isomerization of its polyene sidechain, giving rise to intermediate 
14. Poised for two intramolecular 4π cycloadditions, this intermediate yields the 
cyclopenta[b]furan framework 15. 
Scheme 1.13 Mischne’s Cycloisomerization Cascade to Cyclopenta[b]furans 
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In recent publications, other catalytic systems have also been investigated. Lewis 
acids32 were found to promote the reaction of 4-hydroxypyrones and cyclic 1,3-diketones 
with α,β-unsaturated aldehydes (Scheme 1.14).  
Scheme 1.14 Lewis Acid Catalyzed Cycloaddition of 1,3-Dicarbonyls with α,β-Unsaturated 
Aldehydes 
 
 
A simple phosphoric acid is also an efficient promoter at low loadings, converting 
coumarins and pyrones in the presence of a range of aldehydes to 2H-pyran structures 
(Scheme 1.15).33 
Scheme 1.15 Iminium Catalyzed Cycloaddition of Pyrones with α,β-Unsaturated Aldehydes 
 
 
The expansion of this methodology to access acyclic 1,3-dicarbonyls remains 
challenging. Acyclic diketones usually display internal hydrogen-bonding, making the enol 
form less reactive, and tend to react in a 1,4-addition with iminiums derived from enals.39 
Only a few studies have been reported thus far with α,β-ketoesters.9,40 Lewis base catalysis 
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with phosphines has so far shown more success utilizing acyclic nucleophiles, as 
demonstrated by the Tong group (Scheme 1.16), where allenic acetates were used as 
electrophilic partners.34 In this instance, the formal [3+3] cycloaddition goes through a 
stepwise mechanism based upon phosphine addition to the allenic acetate affording a 
vinylogous ylide 16, which eliminates the acetate to form the conjugated species 17. The 
1,3-diketone, through its enol form, then attacks this activated intermediate yielding the C-
C linked ylide 18. The acetic acid liberated promotes a series of proton transfers, affording 
the O-cyclized adduct 19 which affords the final 2H-pyran 20 after elimination of 
phosphine. 
Scheme 1.16 Phosphine-Catalyzed Cycloaddition of 1,3-Diketones with Allenic Acetates 
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1.2.3 Claisen Rearrangement of Propargyl Vinyl Ethers 
Propargyl vinyl ethers are versatile intermediates in the pursuit of heterocycle 
synthesis. Their use in Claisen rearrangements (known as the Saucy-Marbet reaction) 
represents a simple and powerful transformation toward 5 or 6-membered ring oxygen or 
nitrogen-containing small molecules.41 The key formal [3,3] rearrangement has been 
catalyzed by a range of transition 42–44 and alkynophilic metals.45–48 
Scheme 1.17 Propargylic Claisen Rearrangement as a Platform to Heterocycles 
 
 
Upon metal-mediated 6-endo-dig cyclization of 21, six-membered-ring 22 is 
created and equilibrates with β-oxa allene intermediate 22’. The latter can diverge into two 
pathways (Scheme 1.17) to form either furan 23 through a 5-exo-trig process, or 2H-pyran 
24 via a 6-endo-trig pathway. The latter pathway has been investigated by several groups. 
For example, the Toste group was able to trap the 6-endo intermediate using nucleophiles 
such as water or appended alcohols (Scheme 1.18).48 
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Scheme 1.18 Nucleophilc Trapping of the 6-endo Adduct by Toste and coworkers 
 
 
Kirsch and coworkers showed π-philic metals such as Au(I) or Ag(I)46,47 had 
significant utility with substrates bearing different substitution patterns. This reaction 
proceeds through the use of a catalytic base to engage the allene in an isomerization 
sequence (Scheme 1.19). Ag(I) catalysis was found to be well suited for substituted vinyl 
ethers (R3 ≠ H), whereas Au(I) catalysis performed better with simpler vinyl ether 
substrates (R3 = H, Scheme 1.19).  
Scheme 1.19 Kirsch’s One Pot Propargyl Claisen/Isomerization Sequence 
 
 
  
 
19 
Expanding upon this methodology, Shi and coworkers44 developed a triazole-gold 
catalyst/L-proline isomerization sequence, targeting unsubstituted vinyl ether (R3, R2 = H) 
and affording the corresponding dienals, although fast isomerization of (E/Z) to (E/E)-
dienals was found to be problematic. Terminal vinyl ethers (R3, R2 = H) were not efficiently 
isomerized to dienals using gold catalysis in absence of base. To bypass this issue and 
perform a full and selective sequence to (E/Z)-dienals, the Alabugin group 42,43 screened 
various metals ranging from hard Lewis acids to π-philic metals. Most of them stopped the 
sequence at the allene stage. In contrast, [Rh(CO)2Cl], promoted the desired formal [3,3]-
rearrangement followed by isomerization through proto-demetallation (Scheme 1.20). The 
reaction was found to be stereoselective as the production of the (E,E)-dienal is minimized. 
Scheme 1.20 Rhodium-Mediated Saucy-Marbet Rearrangement/Isomerization Cascade 
 
 
1.2.4 Other Approaches to Oxatrienes/α-Pyrans 
 Outside of the well-established and utilized methods targeting 2H-pyrans or their 
oxatriene valence forms, additional reports have established unique ways of making 
oxatriene/α-pyran. The Stoltz group, during their pursuit of polycyclic pyrans49–51 
developed a method to synthesize such systems. Starting from α-iodinated hexenones or 
unsaturated lactones 25, Stille coupling with β-stannylated acrylates derivatives 26 
afforded dienone 27, which then isomerized in situ to 2H-pyran 28.51  
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Scheme 1.21 Stoltz’s Tandem Stille Coupling/Oxa-6π Electrocyclization 
 
 
Frontier and coworkers, while studying Nazarov cyclizations of substituted dienyl 
diketones, serendipitously observed the formation of an α-pyran structure.52 In the case 
where R1 ≠ H and in the presence of DABCO, the 2H-pyran structure 29 was formed 
selectively (Scheme 1.22) instead of the expected cyclopentenone (Nazarov) adduct 30. A 
possible rationale for this selectivity arises from equilibration of E and Z isomers 31 upon 
addition of DABCO in order to minimize A1,3 strain in isomer 32. Without a deprotonation 
site present to drive the equilibrium to the cyclopentenone structure 33, the tertiary amine 
was preferentially eliminated to afford the Z-isomer 31. This species can further undergo 
oxa-6π electrocyclization to the pyran 29. 
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Scheme 1.22 DABCO-Catalyzed Isomerization of Dienyl Diketones by Frontier and coworkers 
 
 
Another report also demonstrated the intermediacy of α-pyrans en route to 
cyclopentenones. Sarpong et al.53 published an elegant study regarding Pt(II)-catalyzed 
fragmentation of epoxide-containing propargyl esters such as 34. Upon treatment with 
PtCl2, a mixture of cyclopentenone 35 and 2H-pyran 36 was obtained. Resubmitting 36 to 
the reaction conditions afforded structure 35, supporting the role of 36 as an intermediate 
en route to 35. Propargyl ester (34), when exposed to Pt(II), underwent Rautenstrauch-type 
rearrangement 54,55 via 5-exo-dig ring closure and 1,2-acyl migration to afford intermediate 
37. The adjacent epoxide was then able to trap 37, creating zwitterion 38, which releases 
platinum to give rise to the 2H-pyran framework 36. This compound is set for the final 
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stage of this transformation. Compound 36 undergoes retro oxa-6π to 36’, followed by Pt-
mediated acyl shift/4π cyclization to cyclopentenone 35 via orthoester intermediate 39.  
Scheme 1.23 Sarpong’s Pt(II) -Mediated Rearrangement of Epoxy-Propargyl Esters 
 
 
Recently, the Huang goup56 discovered a domino [4+1]-cyclization/rearrangement 
to synthesize 2-methyl-2H-pyrans (Scheme 1.24). First, a tertiary phosphine-mediated 
formal [4+1]-cycloaddition took place between carbonate 40 and β,γ-unsaturated α-oxo 
ester 41, via Morita-Baylis-Hillman and subsequent cyclization, affording the 2,3-
dihydrofuran 42. Second, the 5-membered ring was opened in the presence of pyrrolidine 
and rearranged to pyran 43. The active intermediate in the [4+1] sequence is the dipole 44, 
which was obtained following addition of the tertiary phosphine and decarboxylation of 
the Boc group. Intermediate 44 then reacted with the Michael acceptor portion of 41. The 
created C-C linked zwitterionic species 45 was cyclized to a 2,3-dihydrofuran and 
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eliminated the phosphine catalyst, affording 42. The secondary amine catalyst at this stage 
initiates a deprotonation/protonation sequence to oxatriene/pyran 43. 
Scheme 1.24 Huang’s Domino Reaction of Carbonates and Unsaturated Ketones 
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1.3 Use of 2H-Pyrans in Biomimetic Synthesis of Natural Product  
2H-Pyrans are motifs contained in a myriad of natural products (for a sample, see 
Scheme 1.25).57 The skeleton is widely distributed in prenylated chromenes such as 
panduratin B (46),58 daurichromenic acid (47), gambogic acid (48), and in quinone 
structures (tecomaquinone I (49)). 
Scheme 1.25 2H-Pyran Containing Natural Products 
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Due to their high reactivity, 2H-pyrans have been proposed as intermediates in many 
biosynthetic cycloadditions. Rhododaurichromanic acid A (50) and artocarpol A (51), both 
displaying a 6/4 fused bicycle such as 52, are derived from the [2+2] cycloaddition 
precursors daurichromenic acid (47)59–61 and artocarpol E (53),62,63 respectively (Scheme 
1.25). 2H-Pyrans are additionally thought to be intermediates in biosynthetic Diels-Alder 
reactions. A framework of choice in this case is a 2-oxabicyclo[2.2.2]oct-5-ene 54 (Scheme 
1.26), which arises from a [4+2] cycloaddition between a 2H-pyran diene and an alkene 
dienophile. This bridged bicyclic structure is present in natural products such as torreyanic 
acid (55),12,13,64,65 epoxyquinol A (56),12,66–70 pinnatal (57)71,72 and xanthipungiolide (58).73 
These attractive targets have been the focus of synthetic efforts in order to demonstrate 
their biosynthetic origin and elucidate the role of their 2H-pyran precursors. 
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Scheme 1.26 2H-Pyrans as Intermediates in Diels-Alder Cycloadditions Toward Natural Products 
 
 
1.3.1 Biomimetic Synthesis of Torreyanic Acid, Epoxyquinol A, and Congeners 
Torreyanic acid was isolated by Clardy and coworkers64 in 1996 from the fungus 
species Pestalotiopsis microspora. The natural product demonstrated a selective 
cytotoxicity against several human cancer cell lines. Clardy postulated a potential 
biosynthesis for torreyanic acid (55) would rely on self-dimerization of the monomeric 2H-
pyran 59 which is in equilibrium with its dienal form 59’ through a 6π electrocyclization 
(Scheme 1.27). 
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Scheme 1.27 Clardy’s Biosynthetic Proposal to Torreyanic Acid 
 
 
The Porco laboratory took on the challenge of proving the synthetic feasibility of 
this proposed biosynthesis in the early 2000’s. The first racemic synthesis of torreyanic 
acid65 was disclosed, followed by an enantioselective version.13 Key to the success of this 
tour de force synthesis (Scheme 1.28) was the enantioselective elaboration of 
epoxyquinone 60, which was achieved using tartrate-mediated nucleophilic epoxidation of 
quinone monoketal substrate 61. This intermediate was rapidly advanced to the enantiopure 
epoxyquinone 62. Oxidation with DMP enabled the formation of the desired dienal 63, 
undergoing equilibrium with syn-pyran 64 and anti-pyran 64’. In order to minimize steric 
interactions in the transition state, the thermodynamically favored [4+2] combination 
occurs by an endo, top approach of anti-pyran 64’ with syn-pyran 64 (similar to Scheme 
1.27). A single dimeric compound 65 was thus obtained selectively over other dimerization 
pathways. Facile deprotection of the tert-butyl esters in the presence of TFA finally 
generated (+)-torreyanic acid 66. The absolute stereochemistry of the natural compound 
was assigned to be identical to 66, opposite to the one depicted in Scheme 1.27, (55).  
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Scheme 1.28 Porco’s Biomimetic Synthesis of (+)-Torreyanic Acid 
 
 
This type of dimerization was also thought to take place in the biosynthesis of the 
related epoxyquinols (Scheme 1.29).67 Based on the co-isolation of related natural products 
from the same unknown soil fungus, a proposal by Hayashi and coworkers68 outlined the 
potential dimerization pathways adopted by the syn and anti 2H-pyrans 67 and 67’, in 
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equilibrium with dienal 68. Syn pyran 67 could undergo homodimerization to afford 
epoxyquinol B (69) (endo [4+2]) or a [4+4] cycloaddition to give epoxytwinol A (70). Anti 
pyran 67’ would yield epoxyquinol C (71) upon homodimerization (exo [4+2]) and could 
heterodimerize with syn 67 to generate epoxyquinol A (56). 
Scheme 1.29 Biosynthetic Hypothesis to Epoxyquinols and Congeners 
 
 
Concomitant with their isolation, the first total synthesis of epoxyquinols was 
reported by the Hayashi group in 2002.68 The key epoxyquinol fragment 72, synthesized 
enantioselectively according to a fairly lengthy sequence, was treated with MnO2 to 
promote oxidation of the primary alcohol (Scheme 1.30). A 6π electrocyclization then 
created both syn and anti-pyrans 67 and 67’. 
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Scheme 1.30 Hayashi’s Synthesis of Epoxyquinols and Congeners 
 
 
Heterodimerization yielded epoxyquinol A (56), and syn 67 homodimerization afforded 
epoxyquinol B (69) as major products. In a subsequent study,74 a shorter, scalable route 
was devised to intermediate 72, and after concentration of the crude oxidized mixture from 
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72 and dissolving in toluene, four compounds were isolated (Scheme 1.30). Arising from 
all the potential cyclization modes (cf. Scheme 1.29), epoxiquinols A-C, along with the 
[4+4] dimer epoxytwinol A were synthesized, strongly supporting the biosynthetic 
proposal. 
The Porco group also investigated these dimerization pathways to epoxyquinols A 
and B12,70 and successfully carried out a more selective synthesis of epoxytwinol A (70).75 
This [4+4] dimer was found to be a minor product in the oxidation/dimerization of epimers 
67/67’ (<10% yield).12 In order to favor [4+4] dimerization over [4+2] cycloadditions, a 
blocking group strategy was designed. 
Scheme 1.31 Porco’s Synthesis of Epoxytwinol A 
 
 
Dienal 68 was first generated using a TEMPO oxidation of 72,76 equilibrating to 67/67’ in 
situ. Dichlorodiisopropylsilane then reacted with 67/67’ to obtain the diisopropyl silanol 
diastereomeric mixture 73/73’. Upon standing, the crude mixture selectively 
homodimerized to a bis-silanol protected dimer 74, without any production of [4+2] 
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dimers. Ultimately, treatment with a fluoride source afforded epoxytwinol A (70) in an 
improved yield. 
1.3.2 Biomimetic Synthesis of Antimalarial Naphthoquinones 
Several naphthoquinone-containing compounds isolated from Bignoniacea tree 
species, among them pinnatal (57), have shown low single digit micromolar activity in 
malaria-inducing parasites.71,77,78 Biosynthetically, a unified pathway has been suggested 
to proceed via oxa-6π/cycloadditions of naphthoquinone structures such as 75 (Scheme 
1.32).  
Scheme 1.32 Biosynthetic Proposal to Antimalarial Naphthoquinones 
 
 
Enzymatic oxidation of 75 should produce the dienone 76 which undergoes 6π cyclization 
to pyranokunthone B (77). Further oxidation may generate the enal-containing framework 
78, suited for an intramolecular Diels-Alder cycloaddition that would produce pinnatal 
(57). This adduct could potentially undergo a retro [4+2] cycloaddition and rearrange to 
sterekunthal A (79). 
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 Following this biomimetic proposal, Trauner and coworkers elegantly synthesized 
the series of aforementioned natural products in a chiral, racemic fashion (Scheme 
1.33).15,79 Aldehyde 80 (derived from geraniol) was condensed with naphtoquinone 81 
using a modification of Hsung’s iminium catalyzed [3+3] methodology (cf. Section 1.2.2, 
Scheme 1.11). The resulting 2H-pyran 82, upon protecting group manipulation, was 
advanced to key intermediate 78. Facile intramolecular Diels-Alder cycloaddition then 
took place at room temperature, yielding chiral, racemic pinnatal (57). Under harsh heating, 
this natural product underwent retro-[4+2] cycloaddition to generate (±)-sterekunthal A 
(79), in accordance with the postulated biosynthesis (Scheme 1.32). 
Scheme 1.33 Trauner’s Biomimetic Syntheses of Antimalarial Naphtoquinones 
 
 
In order to obtain pinnatal and derivatives enantioselectively, Trauner hypothesized 
that a dynamic kinetic resolution of rac-78 could be achieved via selective, chiral Lewis 
acid-catalyzed Diels-Alder cycloaddition.15 If only one enantiomer of 78 would participate 
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in the intramolecular [4+2] cycloaddition (Scheme 1.34 (A)), the unreactive enantiomer 
would interconvert to epi-78 via dienone 76, completely driving the isomerism to the active 
form. This concept would require a faster pyran epimerization rate against cycloaddition 
to be effective. Screening a variety of chiral Lewis acids, the best result was obtained with 
a scandium triflate/PyBox system, affording pinnatal 57 in 40% yield and 55% ee (Scheme 
1.23(B)). Despite the yield and enantiomeric excess suggesting only kinetic resolution took 
place, none of the starting 2H-pyran 78 was recovered. 
Scheme 1.34 Attempted Dynamic Kinetic Resolution to Enantioenriched Pinnatal 
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1.3.3 Biomimetic Synthesis of Artocarpols and Daurichromenic Acid Natural Products 
In addition to participating in biosynthetic [4+2] cycloaddition, 2H-pyrans are also 
thought to be intermediates in light-induced [2+2] cycloaddition events, forming a fused 
3-oxabicyclo[4.2.0]oct-4-ene (Scheme 1.25). Rhododaurichromanic acid A (50) and B 
(83) (Scheme 1.35), compounds extracted from the plant Rhododendron dauricum,59 have 
been postulated to be biosynthetically related to the potent HIV inhibitor daurichromenic 
acid (47)80 (EC50 = 5.67 ng/mL). From grifolic acid (84), oxidation followed by oxa-6π 
electrocyclization may afford the 2H-pyran moiety of daurichromenic acid (47). Light 
irradiation could trigger isomerization of the internal E alkene to Z-47’, and both isomers 
would react in an intramolecular [2+2] cycloaddition, generating rhododaurichromanic 
acid A (50) and B (83). 
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Scheme 1.35 Unified Biosynthetic Hypothesis to Chromenic Acid and Related Natural Products 
 
 
Seeking to apply their 2H-pyran forming methodology (cf. Section 1.2.2) to the 
synthesis of complex natural products, Hsung and coworkers designed a concise 
biomimetic synthesis of the daurichromenic acids and their derivatives.60 They reacted 
farnesol-derived α,β-unsaturated aldehyde 85 with 5-methyl-1,3-cyclohexanedione 86 in 
the presence of piperidine in acidic medium (Scheme 1.36). The resulting cyclohexanone 
87 was subsequently acylated with Mander’s reagent (NCCO2Me) and oxidized to 
chromene framework 88. Saponification at that stage failed, yielding decarboxylation. 
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Thus, 88 was utilized in a photochemical [2+2]-cycloaddition directly. A wavelength of 
350 nm was used to induce E/Z isomerization and successful photogeneration of 
rhododaurichromanic acid A (50) and B (83) methyl esters. Final saponification of both 
adducts yielded the desired natural products. 
Scheme 1.36 Biomimetic Synthesis of Daurichromenic Acid and Congeners by Hsung et al. 
 
Another example of 2H-pyrans potentially serving as intermediates in [2+2] 
photocycloadditions can be found in the biosynthetic proposal to artocarpol A (51), 
believed to derive from artocarpol E (53) (Scheme 1.37). These molecules were isolated 
from the root bark of Artocarpus rigida,62,63 and display an intriguing dibenzo[b,f]oxepin 
ring system. Artocarpol A (51) and other family members have notable anti-inflammatory 
properties. Biogenetically, the core structure of artocarpols is proposed to arise from 
reaction of hydroxylated stilbene 89 with prenylated pyrophosphates 90 and 91,62 yielding 
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oxepine structure 92. Following valence isomerism to artocarpol E (53) and [2+2]-
cycloaddition, the required stereocenters for artocarpol A (51) could be set. 
Scheme 1.37 Biosynthetic Access to Artocarpol Natural Poducts 
 
 
Although no synthesis of these natural products has been published so far, a study 
centered on producing analogues of artocarpols was reported by Wilson et al.81 The key 
step in their investigation relied on condensation of the known oxepine 93 with an isomeric 
mixture of citral 94, affording 2H-pyran 95 in moderate yield due to formation of alkene 
isomers. Exposure to light in the presence of benzophenone as a sensitizer promoted [2+2]-
cycloaddition to 96 in 45% yield along with retro oxa-6π ring opened products 97. The 
relative stereochemistry of artocarpol analog 96 at the 6/4/5 system junction was 
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unambiguously assigned using 2D NMR experiments, and corresponds to the relative 
configuration observed in the natural product, supporting the biosynthetic proposal for 
artocarpols. 
Scheme 1.38 Synthesis of Artocarpols Analogues by the Wilson Group 
 
 
1.4 Conclusion and Summary 
 2H-Pyrans, despite their labile character, are ubiquitous in several classes of natural 
products. Several useful synthetic methods have been developed to assemble this sensitive 
moiety, each showing some limitations in terms of accessible substitution pattern around 
the heterocyclic ring. Due to their inherent reactivity, they have been postulated as 
biosynthetic precursors, and were further utilized as key intermediates in many biomimetic 
syntheses relying on cycloadditions. In these cases, preferred reactivity modes that have 
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been discovered include [4+2] dimerizations, intramolecular Diels-Alder annulations, and 
[2+2] photocycloadditions. 
Future developments in this area may warrant additional investigations to expand 
the reaction scope and to access more complex substitutions surrounding the 2H-pyran 
core. Proving their intermediacy in intermolecular Diels-Alder reaction with functionalized 
alkene-containing building blocks should open a new chemical space, outside of their 
established dimerization pathways. This crucial and overlooked aspect will be the subject 
of the following chapters. 
 
  
 
41 
CHAPTER 2                                                                                                                   
A Proposed Biomimetic Synthesis of Swerilactones A and B: 
Elaboration of a 2H-Pyran and Reactivity Studies 
2.1 Introduction 
2.1.1 Isolation of Bioactive Molecules from Swertia mileensis 
 Swerilactones and related natural products were isolated in the late 2000’s by Chen 
and coworkers82–88 from the plant Swertia mileensis and several related species from the 
Gentianacea family. These plants have long been used in traditional Chinese medicine for 
treating viral hepatitis.85 All members of the natural products family display a polycyclic 
framework, containing lactone-pyran fused bicyclic subunits, and are heavily oxygenated. 
Members showcasing a pentacyclic (6/6/6/6) ring system, including swerilactone A82 
(Figure 2.1, (98)), its C7 epimer swerilactone B (99), and the more recently isolated (+)-
sweriledugenin A (100)87 have extremely compact, cage-like structures. Their degree of 
complexity translates into a high number of stereocenters: seven for swerilactone A and B, 
eight for (+)-sweriledugenin A, and two quaternary carbon centers present in each molecule. 
In contrast, swerilactone C (101) and D (102)83 feature a T-shaped structure (cf. Figure 2.1, 
swerilactone D), with five stereocenters and one quaternary carbon center. 
Other members that have been isolated from Nature have exhibited more complex 
polycyclic structures, such as the octacyclic swerilactones H (103) and I85 (104) (Figure 
2.1). The structure and relative stereochemistry for all members of the family were 
confirmed via X-ray crystallography and extensive 2D NMR studies.  
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Confirming their presumed therapeutic effect, all members have shown mild 
bioactivity in a hepatitis B virus assay.85 Despite their appealing framework and bioactivity, 
to date, no synthesis of these compounds has been reported in the literature. 
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Figure 2.1 Representative Lactone-Containing Natural Products Isolated from the Swertia Genus 
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2.1.2 Proposed Biosynthesis and Bioactivity 
 Swerilactones are believed to be derived from secoiridoids85 based on the presence 
of the δ-lactone framework (Figure 2.2). Iridoids, a group of monoterpenoids featuring a 
methylcyclopentane skeleton, are a privileged chemotype present in >1000 isolated 
compounds from diverse plant sources, including Scrophulariaceae, Rubiaceae, Labiatae, 
Gentianaceae, Verbenaceae, and Oleaceae.4 Of note, most of the iridoids in the 
Gentianaceae family, from which the Swertia genus is derived, belong to the secoiridoid 
subclass. 
Figure 2.2 General Structure and Numbering System of Iridoids and Secoiridoids 
 
 
A potential biosynthetic pathway has been hypothesized for swerilactones A and B 
with aldol condensations as key C-C forming steps.85 Iridotrial (105) is proposed to 
undergo a series of enzymatic transformations to arrive at intermediate 106 (Scheme 2.1). 
This compound could then diverge into two key frameworks 107 and 108 via differentiated 
hemiacetal cyclizations followed by oxidation. The α- and γ-formylated lactones 107 and 
108 could potentially couple together via aldol reactions to generate a new cyclohexane 
ring-containing structure 109 (Scheme 2.1) via C3-C4’ and C4-C8’ bond formations. This 
product would be suited to undergo subsequent aldol cyclization between C9-C3’ yielding 
polycycle 110. Upon water loss and ketone reduction at C8, lactone 111 could form and be 
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reduced to core structure 112. Additional loss of water would create a transient carbocation 
at C3 that could be trapped by the adjacent alcohol at C8, thereby affording the final 
bridgehead C-O bond. Similar transformations have been proposed to generate the other 
members of the family, relying on aldol reactions as key transformations.85 
Scheme 2.1 Proposed Biosynthesis of Swerilactone A and B by Geng and Coworkers 
 
 
In terms of bioactivity, most members are active against one or more components 
of the hepatitis B virus (Table 2.1). Swerilactone A, C and D have weak single-digit 
millimolar inhibition activity against secretion of surface (HBsAg) and envelope (HBeAg) 
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antigens as determined by a transfected HBV cell line assay. Swerilactone E and I were 
found to be more potent with sub-millimolar IC50 values. Swerilactone H, sweriledugenin 
and sweriyuannanlactone, on the other hand, were only active in inhibiting the HBV DNA 
replication mechanism but inactive against the secretion of both antigens HBeAg and 
HBsAg.  Interestingly, modern treatments against the Hepatitis B virus are small molecules 
derived from nucleotides and nucleosides.89 The current standard-of-care to treat hepatitis 
B is the nucleoside-based lamivudine developed by GlaxoSmithKline (cf. Table 2), which 
targets the virus’s reverse transcriptase and displays IC50 values between 0.01-3 μM.89 
Table 2.1 Anti-HBV Activities of Swerilactones and Related Natural Products 
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In this regard, in addition to unambiguously determine its absolute configuration, a 
synthesis of swerilactone A (or its core structure) could give access to a new, distinct class 
of small molecules active against the Hepatitis B virus, and represent a potential stepping 
stone toward a novel treatment. 
 
2.2 Retrosynthetic Approaches to Swerilactones A and B 
2.2.1 First Retrosynthetic Analysis 
 In our initial synthetic analysis, we sought to target swerilactone A and its C7 
epimer swerilactone B as a first approach to the synthesis of this family of natural products. 
As an alternative to their proposed biosynthesis based on successive aldol reactions 
(Scheme 2.1), we thought a viable way of assembling the core structure of swerilactone A 
and B would rely on a Diels-Alder cycloaddition as a key step. 
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Scheme 2.2 Proposed Biomimetic Access to Swerilactone A 
 
 
For the synthesis of swerilactone A, we hypothesized that a first disconnection 
could be made between the α position of the 2H-pyran fused lactone and the δ position of 
the spirocyclic lactone (Scheme 2.2). Deprotonation at the γ1 position of core 113 may 
trigger a 1,6-deconjugative Michael addition.90,91 Intermediate 113 could potentially arise 
from biomimetic Diels-Alder cycloaddition of two key regioisomeric lactones: the enol 
tautomer of lactone 114 and a fused 2H-pyran lactone 115, undergoing a dynamic oxa-
6π/retro-6π electrocyclization. 
At the outset of our studies, it was unknown if the polarization of components 115 
and 114 would allow for a normal demand or an inverse demand Diels-Alder cycloaddition. 
Figure 2.3(A) depicts the Frontier Molecular Orbital (FMO) analysis and the prevalent 
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HOMO-LUMO interaction associated with each mode of cycloaddition. A smaller energy 
gap between the HOMO of the diene and the LUMO of the dienophile is at play in a normal 
demand Diels-Alder. This is due to the HOMO raising effect of the electron-donating 
substituent on the diene and the LUMO lowering effect of the electron withdrawing group 
on the dienophile. In the case of inverse demand mode, the smallest energy gap is now 
found between the LUMO of the diene diene and the HOMO of the dienophile. This is also 
explained by the electron withdrawing effect of the substitutents on the diene, which lowers 
its LUMO, and the electron donating effect of the substituents on the dienophile, which 
raises its HOMO. Few examples of inverse-demand Diels-Alder reactions using enol or 
enolates have been reported (Figure 2.3 (B));92,93 enol ethers are more commonly 
employed in this cycloaddition mode, due to enhanced nucleophilicity and stability.94  
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Figure 2.3 (A) FMO Analysis for Different Diels-Alder Modes and (B) Example of Inverse Demand 
Reaction 
 
 
Following the FMO principles outlined in Scheme 2.3, we envisioned that 
changing the substitution from a free enol 114 to an enol ether may tune the reaction 
electronics. For example, by accessing the TBS- or tert-butyl protected enol (114a and 
114b), we could potentially invoke an inverse demand process. Alternatively, an acetate-
substituted enol (114c) may enable a normal demand cycloaddition.  
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Figure 2.4 Potential Substitution of Enol Lactone 114 
 
 
Additionally, substitution might help lock the enol ether stereochemistry to the (E)-
enol form, which needs to be on the same side as the propenyl side chain according to our 
proposed Diels-Alder transition state (cf. Scheme 2.2). Since the free enol lactone 114 can 
adopt an (E) or (Z)- conformation, the cycloaddition event with 2H-pyran 115 provides 
multiple possibilities in terms of regiochemical and stereochemical outcomes. A dienophile 
approach away from the pyran methyl group, a commonly observed restriction in related 
pyran systems (Chapter 1, Section 1.3), results in eight transition states, four for the (E)-
enol (Figure 2.5) and four for the (Z)-enol 114 (not shown). 
Figure 2.5 Four Possible Transition States between (E)-Enol 114 and Pyran 115 
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In the face of executing a complex Diels-Alder cycloaddition, we thought an 
alternative, stepwise reactivity mode of enol 114 could be proposed. In spite of being 
widely postulated as concerted transformations in Nature, 95,96 most Diels-Alder 
cycloadditions effected by enzymes are thought to proceed through stepwise mechanisms. 
For instance, macrophomate synthase (MPS) had been thought to promote a concerted 
[4+2] cycloaddition step97 and its crystal structure bound to its molecular target was 
obtained (Scheme 2.3).98 It is now known to catalyze the stepwise reaction between 
substituted 2-pyrone 116 and pyruvate magnesium enolate 117 to form a bicyclic adduct 
118. Using a model of the active site of MPS complexed with 117, DFT calculations 
suggest an energetically favored pathway through intermediate 119 via a Michael/aldol 
cascade, with both transition states >10 kcal/mol lower in energy than the concerted Diels-
Alder transition state.99 
Scheme 2.3 Stepwise Formal Diels-Alder Cycloaddition Catalyzed by Macrophomate Synthase 
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 Inspired by this mechanistic interpretation, we imagined two viable stepwise 
pathways to assemble the core structure. Leveraging the valence isomerism of 2H-pyran 
115 in its closed form, enol lactone 114 could attack at the electrophilic position of α-pyran 
115 in a Michael addition fashion (Scheme 2.4, (A)). The resulting extended enolate 120 
may further react with the aldehyde in a vinylogous aldol reaction, thereby creating the 
core spirocyclic scaffold 113. Alternatively, dienal 115’ could undergo an aldol reaction 
with enol lactone 114, affording hydroxyl anion 121, which may further cyclize to provide 
the same extended enolate 120 (Scheme 2.4, (B)). Aside from representing an alternative 
avenue to concerted [4+2] cycloaddition pathways, it would also permit investigation of 
asymmetric processes e.g. engaging the dienal valence isomer with chiral ligand/metal 
complexes. 
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Scheme 2.4 Stepwise Pathways to Swerilactone Core 
 
 
2.2.2. Revised Retrosynthetic Analysis: Ketene-Diene Diels-Alder Cycloaddition 
Approach 
 Given the large number of potential transition states for a concerted reaction 
pathway with (E)- and (Z)-enol 114 and the questions regarding the preferred reactivity 
modes adopted by pyran 115 and enol 114, we decided to explore the possibility of a ketene 
as a dienophile instead of an enol. We anticipated a ketene dienophile would have the 
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advantage of an increased reactivity and would simplify matters in terms of regiochemical 
and stereochemical outcomes.  
In collaboration with Prof. Richard Johnson (University of New Hampshire), DFT 
calculations using a model ketene dienophile were performed. Under a restricted pyran 
facial selectivity, and accounting for a higher reactivity of the ketene C=C bond, four 
transition states can presumably take place (Figure 2.6). Prof Johnson’s preliminary DFT 
calculations indicated the lowest-energy transition state led to the desired regiochemical 
and stereochemical outcome (Figure 2.6, transition state syn-endo (A), ΔE = 0 kcal/mol). 
The three other transitions states, syn-exo (B), anti-endo (regioisomer (C)), and syn-exo 
(regioisomer (D)) were calculated to stand respectively at 2.5, 6.3 and 7.4 kcal/mol higher 
in energy than the one needed for our cycloaddition (Figure 2.6). 
Figure 2.6 Ketene-Pyran Cycloaddition: Four Possible Transition States 
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The lowest energy transition state (A) (ΔE = 0 kcal/mol) is depicted in Figure 2.7, showing 
the 2H-pyran being approached from its α face (methyl group pointing upward) by the 
ketene in an endo mode.  
Figure 2.7 Ketene-Pyran Lowest Energy Transition State (A) (DFT B3LYP/6-31G**) 
 
 
These theoretical calculations led us to revisit our retrosynthetic analysis (Scheme 
2.5). The key [4+2] cycloaddition could take place between α-pyran 115 and a ketene 
derived from lactone 122. The resulting ketone 123 would then need to be selectively 
reduced before or after the 1,6-deconjugative Michael addition step.  
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Scheme 2.5 Revised Retrosynthesis of Swerilactone A 
 
 
Ketenes are well-known to participate in thermal [2+2] cycloaddition rather than 
normal demand [4+2] with carbodienes (cf. Scheme 2.6 (A), reaction of cyclopentadiene 
with diphenylketene).100 This is due to a more favorable [π2s+π2a] overlap of the ketene 
π* with the HOMO of the alkene π system, inducing an orthogonal approach (Scheme 2.6 
(B)). 
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Scheme 2.6 Typical Ketene Reactivity in Thermal Diels-Alder Cycloadditions and FMO Analysis 
 
 
However, some literature reports have showed a preference for [4+2] cycloaddition 
with bulky diene partners, in which the steric hindrance prevented the ketene from adopting 
an antarafacial approach (Scheme 2.7 (A)).101 With heterodienes, ketenes can be trapped 
in the presence of a chiral Lewis base, forming a ketene enolate that further reacts with the 
heterodiene in a stepwise manner. This strategy constitutes an inverse-demand 
cycloaddition94 and yields a formal Diels-Alder heterocycloadduct enantioselectively. A 
number of methodologies taking advantage of this concept to create heterocycles102 have 
been published using cinchona alkaloid derivatives,103,104 NHCs105–107 or 
benzotetramisoles108,109 as Lewis bases to generate transient ketene enolates. A 
representative application of this strategy by Lectka and coworkers is outlined in Scheme 
2.7 (B).110 In this example, an acyl chloride forms a ketene upon deprotonation with 
Hünig’s base, which is further trapped as a ketene enolate in the presence of the cinchona 
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alkaloid which reacts in a stepwise fashion with an o-quinone methide diene. The resulting 
cycloadduct is obtained in high enantioselectivity. 
Scheme 2.7 Typical Ketene Reactivity Profile in [4+2] Cycloadditions 
 
 
Based on these literature precedents, targeting a ketene precursor such as lactone 
122 would offer some versatility. In the case where a concerted [4+2] cycloaddition did 
not exist, we could switch easily to a ketene enolate mechanism. The reaction in the latter 
case would proceed in a stepwise manner, similar to the proposal in Scheme 2.4. The 
generated ketene could be intercepted with a chiral Lewis base, yielding a reactive 
ammonium or azolium enolate 124 (Scheme 2.8). This species could converge to enolate 
125 in two distinct pathways, whether directly via Michael addition or indirectly through 
hydroxyl anion 126. Closure of 125 should generate the oxidized core for swerilactone A 
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123 and recycle the nucleophilic catalyst. Of note, both pathways could proceed 
stereoselectively. 
Scheme 2.8 Potential Stepwise Pathways to an Oxidized Swerilactone Core 
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2.3. Construction of a Fused 2H-Pyran Lactone Fragment 
2.3.1 Previous Synthesis 
The required first fragment according to our retrosynthetic analysis (Section 2.2) is 
the bicyclic, lactone fused 2H-pyran 115. At the start of our synthetic studies, a publication 
by Tan and coworkers111 illustrated the successful synthesis of 2H-pyran 115 (Scheme 
2.9). Starting from crotonaldehyde as their source of the trans-propenyl moiety, they were 
able to synthesize enone 127 via an aldol reaction with ethyl acetate, followed by TBS 
protection and DMP oxidation (not shown). A second aldol reaction of 127 with methyl-3-
hydroxypropionate 128 afforded 129 with the full carbon containing framework. Finally, 
protecting group removal and lactonization under heating provided lactone 130. 
Interestingly, it was demonstrated that upon treatment with DMP, lactone 130 
produced the desired 2H-pyran 115 (in a 4:1 ratio favoring the closed form 115), along 
with a minor amount of lactol 131. The presence of 131 in the reaction mixture was shown 
to arise from the in situ formation of 2H-pyran 115, which in contact with singlet 1O2, 
reacted in a [4+2] cycloaddition to forms endoperoxide 132. A Kornblum-DeLaMarre 
rearrangement112 then occured in the presence of base, yielding lactol 131. 
 
 
 
 
 
  
 
62 
Scheme 2.9 Tan’s Synthesis of 2H-Pyran 115 and Subsequent Cycloaddition 
 
 
These oxidation results were extremely encouraging, as they clearly showed the 
ability of 2H-pyran 115 to act as a diene in a cycloaddition event. More importantly, in 
accordance with previous observations on related pyrans,12,13,65,70,74,75 compound 115 
seems to impart a facial selectivity (trans:cis d.r 15:1), with 1O2 approaching from the least 
hindered face of the 2H-pyran, away from the methyl group. With this relevant precedent 
in hand, we decided to design our own shorter route to 2H-pyran 115. 
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2.3.2 First Synthetic Route: Cuprate Addition of Metallated Propenyl and Oxidation of 
Formylated Lactone  
We envisioned a streamlined access to pyran 115 by a three step route from the 
commercially available unsaturated lactone 133 (Scheme 2.10). Cuprate addition of a 
suitable metallated propenyl species such as 134 followed by enolate trapping with a 
formate equivalent should provide α-formylated lactone 135. Further oxidation of 135 
could produce 115. 
Scheme 2.10 First Retrosynthetic Strategy to 2H-pyran 115 
 
 
Preliminary experiments quickly revealed that this one pot process was possible but 
that it also may not be an ideal reaction candidate for scale-up purposes (Scheme 2.11 (A)). 
Indeed, the yields of intermediate 135 were unreproducible, and an undesired side product 
136 was isolated, arising from 1,4-addition of intermediate enolate 137a into the starting 
lactone 133. Upon searching for literature conditions to minimize  this side reaction, we 
found that tributylphosphine113 was reported to be an effective copper ligand in the Michael 
addition of unsaturated lactones. Indeed, upon use of tributylphosphine in generating 
cuprate 134b, no side product was observed; however, we were still plagued with other 
issues (Scheme 2.11 (B)). For instance, purification of the crude product was particularly 
cumbersome with a mixture of 1,4-adduct 138, lactone 135, and tributylphosphine 
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requiring separation. Intermediate 138 was also found to be volatile, which made the 
purification step more challenging. 
Scheme 2.11 Cuprate Addition Studies to α,β-unsaturated Lactone 133 
 
 
 A higher yielding procedure involved a stepwise route, involving initially a 
conjugate addition of organocuprate 134b to adduct 138 (Scheme 2.11 (C)). After careful 
purification and handling, the subsequent enolate formylation step was successfully 
conducted using LDA in THF followed by enolate quenching with 2,2,2-trifluoroethyl 
formate,114,115 affording the key α-formylated lactone 135. 
Our focus next shifted to the oxidation step to convert 135 to 2H-pyran 115. An 
extensive screen was conducted featuring a wide range of oxidation methods (Table 2.2). 
Stoichiometric116 or catalytic DDQ,117–119 selenium oxide elimination, or Saegusa 
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protocols afforded the desired product in low yield, and both PIDA and DMP oxidations 
were unsuccessful. Oxidants known to promote 2H-pyran formation in related 
epoxyquinol-containing pyrans70,120 including Bobbitt’s reagent and TEMPO/CuCl 
(entries 2 and 4 respectively, Table 2.2) failed to promote the targeted transformation. 
Metal-mediated reactions were equally unproductive, despite having shown great success 
in previous dehydrogenations of cyclic ketones,121 in allylic C-H activation/β-hydride 
eliminations122 or dehydrogenations of cyclohexenones123 (entries 3, 5 and 6, Table 2.2). 
Table 2.2 Oxidation Screen toward 2H-Pyran 115a 
 
a Reactions run on a 10-20 mg scale under an atmosphere of air, argon or oxygen
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 Of note, several conditions gave interesting results. IBX induced α-hydroxylation 
(Scheme 2.12 (A), product 139), enamine-based Saegusa oxidations124,125 yielded enamine 
formation (Scheme 2.12 (B), product 140) or an unexpected Pd(II)-mediated oxidative 5-
exo-trig cyclization to afford 5-6 fused lactone 141 in the presence of a sub-stoichiometric 
amount of diphenyl prolinol (Scheme 2.12 (B)). To the best of our knowledge, formation 
of 141 is the first example of a Wacker type oxypalladation of an α-formylated lactone. 
Literature precedents have demonstrated the ability of tethered alcohols and phenols to 
partake in such oxypalladation process, racemically126 or enantioselectively127,128 by using 
a chiral ligand such as sparteine or bisoxazoline derivatives. We believe that the prolinol 
acts as a ligand for Pd(II) in the present case, as control experiments without this ligand 
showed decomposition. It is unclear at this stage if the chiral enantiopure L-prolinol imparts 
asymmetric induction into this process. Further experiments such as conducting the 
reaction with a racemic mixture of diphenyl prolinol and comparing the reaction outcome 
by chiral HPLC would help assess potential for an enantioselective transformation. 
Scheme 2.12 Other Oxidative Conditions of Interest 
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Given the unexpected difficulty to promote an effective and reproducible oxidation 
of α-formylated lactone 135, an alternative synthetic route was explored, using an aldol 
condensation as the key step. 
 
2.3.3 Second Synthetic Route: Use of an Allylic 1,3-Diol in an Aldol Condensation 
We hypothesized that a short alternative route to the cuprate 
addition/formylation/oxidation sequence may arise from an intramolecular aldol 
condensation of enone ester 142 (Scheme 2.13). This oxidized building block was 
imagined to be derived from transesterification of diol 143 with a masked formylacetic 
ester 144. 
Scheme 2.13 Second Route: Retrosynthetic Analysis 
 
 
1,3-Diol 143111 was transesterified with the commercially available methyl 3,3-
dimethoxypropionate 144 in the presence of Otera’s catalyst (A) (Scheme 2.14).129,130 The 
resulting coupled product 145 was then efficiently oxidized with DMP to rapidly afford 
the targeted enone ester 142. 
 
 
  
 
68 
Scheme 2.14 Synthesis of β-Dimethyl Acetal Ester 142 
 
 
A range of methods were subsequently screened to effect the deprotection of the 
dimethyl acetal, followed by intramolecular aldol condensation into the enone moiety of 
142. Both Lewis and Brønsted acids (including combinations of), as well as basic 
conditions were tested (Table 2.3). La(III), Bi(III) and Er(III) metals degraded the starting 
material or lead to ester cleavage. The strongly coordinating Lewis acid BF3.OEt2 induced 
an undesired methanol elimination to form enol ether C. Among the acidic conditions tried, 
Amberlyst-15 promoted conversion to a mixture of deprotected enol ether C and formyl 
acetic ester D, the latter rapidly degrading upon standing. A combination of Lewis and 
Brønsted acids were equally uneffective, and induced decomposition of the starting 
material. Dual use of magnesium bromide dietherate and trimethylamine, a common soft 
enolization tactic131 aimed at lowering the pKa of the α-ester hydrogen, cleanly afforded 
enol ether C. Attempts at resubjecting product C to several hydrolysis conditions led to 
degradation or the formation of the sensitive, quickly decomposing aldehyde D. With this 
extensive screening yielding unproductive pathways, a third route was pursued. 
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Table 2.3 Aldol Condensation Screena 
 
a Reactions run on a 10-20 mg scale, under air or nitrogen atmosphere. Yields refer to pure, isolated compounds.  
2.3.4 Third Synthetic Route: Metal-Mediated Diyne Cyclization 
Formal [2+2+2] diyne cyclizations have been successfully carried out to form 2H-
pyrans using metals such as Ni(0), Rh(I) and Ru(I) (Chapter 1, Section 1.2.1). We wished 
to apply a similar methodology to cyclize diynoates of general structure 146 (Scheme 2.15) 
to α-pyran 147. It was anticipated 146 could be accessed by esterification of TMS-protected 
propiolate 148 with but-3-yn-1-ol 149. 
 
 
 
  
 
70 
Scheme 2.15 Planned Metal Mediated Cyclization of Diynoate 146 
 
 
To this end, diynoate 146 was synthesized in three steps from TMS acetylene 150 
(Scheme 2.16). Lithiation of the terminal alkyne followed by anion quenching with dry 
CO2(g)
132 afforded the TMS protected ynoate 148.133 From 148, esterification was effected 
via in situ acyl chloride formation,134 followed by nucleophilic displacement with but-3-
yn-1-ol 149. Final lithiation of the resulting terminal alkyne 151 followed by addition into 
acetaldehyde enabled access to racemic diynoate ester 146. 
Scheme 2.16 Access to Diynoate 146 
 
 
We next focused our efforts on triggering the cycloisomerization using metals such 
as cationic ruthenium and rhodium (Scheme 2.17) in several solvents.20,25 Disappointingly, 
these conditions did not produce the desired cyclized framework of 147, and we instead 
observed ester cleavage of 146. 
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Scheme 2.17 Metal-mediated Cyclization of Diynoate 146 
 
 
2.3.5 Fourth Approach: Saucy-Marbet Rearrangement of a Propargyl Vinyl Ether 
We envisaged a potential way to alleviate ester cleavage would start by first 
installing the 2H-pyran moiety followed by lactonization (Scheme 2.18). Literature 
precedents46,135 demonstrated the formation of 2H-pyran structures via Ag(I) or Au(I)-
mediated Claisen rearrangement/isomerization of propargyl vinyl ethers (Chapter 1, 
Section 1.2.3). We hoped a similar transformation would be successful in the production 
of pyran 115. Claisen rearrangement of propargyl vinyl ether 152 would yield 2H-pyran 
153, which could be further deprotected and lactonized to pyran 115. 
Scheme 2.18 Potential Route to 2H-Pyran 115 via Claisen Rearrangement/Isomerization 
 
 
Propargyl vinyl ether 152 was thus easily assembled by lithium acetylide addition 
of TBS-protected but-3-yn-1-ol into acetaldehyde,136 followed by tributylphosphine 
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mediated conjugate addition137 of the resulting alcohol with methyl propiolate. At this 
stage, a Saucy-Marbet rearrangement was attempted. Screening a variety of Lewis acids 
and alkynophilic metals (Scheme 2.19), we discovered that AuCl most efficiently 
promoted the transformation to allene 154, which upon DBU treatment isomerized to α-
pyran 153. 
Scheme 2.19 Saucy-Marbet Rearrangement: Metal Screen 
 
 
By following this reaction by 1H NMR, we observed clean conversion of propargyl 
vinyl ether 152 (Figure 2.7 (A)) under mild heating at 30 ˚C in the presence of Au(I) to 
allene 154. This is marked by the downfield shift of the enol ether proton H1 from a doublet 
at 7.5 ppm to a 9.6 ppm singlet signal, corresponding to an aldehyde proton (Figure 2.7 
(B)). After adding a catalytic amount of DBU and stirring the reaction at room temperature, 
clean isomerization to pyran 153 was observed, evident by H1 shifting from 9.6 ppm to a 
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singlet at 7.6 ppm (Figure 2.7 (C)), characteristic of a 2H-pyran structure. Compound 153 
was isolated upon silica gel chromatography but required storage at low temperature (-20 
˚C) to minimize degradation. In CDCl3, this compound only exists as the pyran valence 
isomer, with no detectable formation of dienal 153’. 
Figure 2.7 Stacked NMR Plot Illustrating the Rearrangement of Propargyl Vinyl Ether 152 to Pyran 
153 
 
 
 We then turned our attention to the deprotection of the silicon protected primary 
hydroxyl and methyl ester functionalities of 153 to induce final lactonization. Acidic 
conditions and fluoride sources were tested (Scheme 2.20) and gave low to moderate yield 
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of the deprotected alcohol, potentially due to the labile character of the already present 
pyran functionality, which has a tendency for decomposition. Attempts to lactonize the 
resulting deprotected alcohol 155 with DBU or under thermal heating failed and resulted 
in decomposition (Scheme 2.20). 
Scheme 2.20 Attempted Deprotection/Lactonization to Pyran 115 
 
 
An intramolecular version of the Saucy-Marbet reaction was alternatively 
investigated. Transesterification of diol 156 with methyl propiolate in the presence of 
Otera’s catalyst129,130 yielded diynoate 157. Tributyphosphine catalyzed etherification 
afforded a mixture of dimer (158) and trimer vinyl enol ether macrocycles. A Saucy-
Marbet rearrangement was attempted on this species and gave no reaction. 
Scheme 2.21 Alternative Access to Pyran 115: Intramolecular Propargyl Claisen Rearrangement 
 
 
 Future plans include a larger screen of lactonization conditions (acidic, basic and 
Lewis acid conditions) from alcohol 155 to 2H-pyran 115. Despite the challenges faced in 
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designing a shorter route to α-pyran 115, we remained commited in exploring its potential 
reactivity in Diels-Alder events and other relevant transformations toward swerilactone A. 
 
2.4 Reactivity of the Fused 2H-Pyran Lactone in Diels-Alder Cycloadditions 
The fully lactonized α-pyran 115 was synthesized according to Tan’s published 
route (Scheme 2.9).111 In our hands, the route proved scalable, in which an appreciable 
amount (~1g) of material was synthesized in a single batch. The ratio between the two 
valence isomers (115:115’) was found to vary in different solvents as determined by 1H 
NMR analysis. In all cases, the 2H-pyran is favored, with the highest ratio observed in 
deuterated methanol and chloroform (3.6:1 and 3.5:1 respectively), and reaching almost 
equal proportion to the dienal in DMSO-d6 (Table 2.3). The latter result is in accordance 
with previously reported behaviors of 2H-pyrans, where the dienal content increased in 
polar aprotic solvents due to dipole minimization.5 In our case, aprotic solvents with a high 
dielectric constant increase the content of the dienal form 115’ (cf. (CD3)2CO, CD3CN, 
DMSO-d6). 
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Table 2.4 Solvent Effect on Valence Isomerism of Pyran 115 
 
2.4.1 Model Ketene Study 
With an ample amount of 115 at our disposal, we turned our attention to a model 
ketene cycloaddition study. In this regard, 115 was reacted with isobutyryl chloride in the 
presence of Hünig’s base or triethylamine (Scheme 2.22).  
Scheme 2.22 Ketene [4+2] Cycloaddition Model Studies 
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To our surprise, the acyl chloride was not deprotonated under these conditions to 
form a ketene. Instead, acylation of 115 to compound 159 was observed, along with the O-
acylated product 160. A rationale behind these results may be explained by looking closely 
at the equilibrium of the valence isomerism for pyran 115 (Scheme 2.23). In its closed 
form, 115 theoretically possesses one electrophilic position (shown in red) and one 
nucleophilic position (shown in blue), based on electron delocalization along the ring 
system. In its opened dienal form 115’, two electrophilic positions coexist (shown in red). 
In the presence of a suitable base, the acidic δ hydrogen of 115’ can be deprotonated to 
form the cross-conjugated, extended enolate 161. The latter compound is responsible for 
production of the O-acylation product 160, a behavior reported on similar enal systems 
upon deprotonation with triethylamine.138 
Scheme 2.23 Impact of Valence Isomerism on Acylation 
 
 
To avoid these side-reactions, slowly adding the 2H-pyran 115 into a solution of 
the acyl chloride-triethylamine solution was attempted. Polymerization of the ketene was 
observed and 115 was recovered. 
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2.4.2 Reactivity in Thermal Diels-Alder Cycloadditions 
Despite the reactivity issues encountered carrying out a ketene cycloaddition study 
with simple acyl chlorides (which would require bases strong enough to deprotonate 115’), 
we tested the normal demand reactivity of 115 to gain valuable insights (Scheme 2.24). To 
this end, thermolysis of 115 in the presence of several electron poor dienophiles such as 
methyl vinyl ketone, N-benzyl maleimide, and N-aryl maleimide yielded the desired 
cycloadducts 162, 163, and 164, respectively, in 30-40% yield. 
Scheme 2.24 Normal Demand Diels-Alder Reactivity of α-Pyran 115 
 
 
The configuration of these adducts was unambiguously assessed using 2D NMR 
techniques (cf. Scheme 2.25 for the computed lowest energy conformer of 163 and key 
NOESY and HMBC correlations). As predicted by frontier molecular orbital theory, due 
to secondary stabilizing interactions of the electron poor dienophiles, the endo adducts are 
the major products and display the expected regioselectivity based on predicted structure 
polarity/orbital coefficients. Additionally, the methyl group contained in 115 impart facial 
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selectivity, forcing the dienophile to approach from the most accessible face, an 
observation made by the Tan group in their 1O2 cycloaddition.
111 
Scheme 2.25 Lowest Energy Conformer of Adduct 163 (MMFF) and Key 2D NMR Correlations 
 
We observed moderate yields for these reactions, and a small quantity of 115 was 
recovered in each case. A test reaction was carried out to help understand if a 
decomposition pathway was impairing our yield or if additional side-products were 
formed. Heating 115 in toluene by itself did not provide in situ dimerization of 115, 
surprisingly given the large body of literature taking advantage of 2H-pyrans ability to self-
dimerize (Chapter 1, Section 1.3.1).12,74,139 Other literature reports demonstrated the 
potential of 2H-pyrans to undergo 1,5-hydride shifts, forming acyl ketenes140 (Scheme 2.26 
(A)) and 1,7-hydride shifts (Scheme 2.26 (B)).13 
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Scheme 2.26 Reported Side Reactions of Dienals through Hydride Shifts 
 
 
In our case, decomposition slowly occured over time, with complete decomposition 
observed at temperatures greater than 90 ˚C (Scheme 2.27 (A)). Improving the yields for 
this series of experiment may be possible by degassing the solvent and adding the radical 
quencher butylated hydroxytoluene (BHT) to minimize radical side reactions.  
Of note, inverse demand cycloaddition mode was also investigated with ethyl vinyl 
ether, but gave rise to 2H-pyran decomposition and a very low yield (<5%) of cycloadduct 
as assessed by crude 1H NMR (Scheme 2.27 (B)). Nonetheless, as a proof-of-concept, these 
experiments clearly show the ability of 115 to partake in normal demand [4+2] 
cycloaddition and its lack of reactivity in the inverse demand mode. 
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Scheme 2.27 Attempted Self-Dimerization of Pyran 115 and Inverse Demand Cycloaddtion 
 
 
2.4.3 Radical Cation [4+2] Cycloaddition 
Sorting through the literature for Diels-Alder processes, we became interested in a 
different Diels-Alder mode: cation radical cycloadditions of enols and their 
derivatives,141,142 mediated by photocatalysts or chemical oxidants. Expanding upon Prof. 
Bauld’s use of triarylaminium salts to promote radical cation [4+2] cycloaddition of 
carbodienes with alkenes,143–145 Schmittel and coworkers investigated the reaction of 
ketenes with carbodienes in the presence of a one electron oxidant such as 
triarylamminiumyl hexafluoroantimonate.146,147 Contrary to thermal activation, the 
reaction afforded [4+2] cycloadducts, avoiding the common [2+2] pathway (Scheme 2.28 
(A)). 
This strategy could also represent an amenable avenue in our proposed biomimetic 
approach (Scheme 2.2). Similarly to the well-known DeMayo cyclization,148 1,3 
dicarbonyls and ketones in their enol tautomer form are also suitable to single electron 
transfer.149,150 Flowers and coworkers conducted chemical oxidation of 1,3-dicarbonyls 
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and using Ce(IV) and observed a radical cation formation,151 followed by intramolecular 
cyclization (Scheme 2.28 (B)). Silyl enol ethers can be oxidized to a radical cation and 
were shown to participate in radical cyclization. 152–154 Trauner utilized this strategy to 
elegantly assemble a precursor to (-)-guanacastepene E via anodic oxidation (Scheme 2.28 
(C)).153  
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Scheme 2.28 Overview of Radical Cation Cyclization of Ketenes and Enol Derivatives 
 
 
 More recently, advances in photoredox catalysis155 have inspired the Yoon group, 
who reported the use of ruthenium photocatalysts in the excited state to promote one 
electron oxidation of stilbene derivatives, in which a cation radical can participate in Diels-
Alder cycloadditions with several inert dienes (Scheme 2.29 (A)).156 The mechanism for 
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this transformation is believed to rely on a radical chain process. Trans-anethole 165 (Eox= 
1.1 V) is oxidized to a radical cation 166 +. by the excited photocatalyst *Ru(bpz)3
2+ 
(Eox=1.4 V). This oxidized species further reacts with isoprene 167 to generate a stabilized 
radical cation cycloadduct 168+. Propagation of the radical chain process and formation of 
product 169 are induced by the oxidation of another equivalent of trans-anethole 165 by 
the oxidized cycloadduct 168+..157 
Yoon and coworkers applied their methodology to the synthesis of heitzamide A, 
and showcased the complementary character of radical cation cycloaddition. The 
umpolung strategy imparted by a cation radical formation gives rise to coupling products 
between electronically mismatched sites. The end result is a reverse of the inherent polarity 
of both partners. The innate polarization of both neutral diene and dienophile predicts the 
formation of a regioisomer of heitzamide A in the case of a thermal [4+2] cycloaddition 
and is verified experimentally (Scheme 2.29 (B)). In contrast, using a Ru(II) photocatalyst 
to trigger the photosensitized electron transfer (PET), a precursor of heitzamide A is 
obtained in good yield (Scheme 2.29 (C)). 
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Scheme 2.29 Yoon’s Radical Cation [4+2] Cycloaddition and Application to Natural Product 
Synthesis 
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Inspired by this body of work and the possibility of 115 being a competent diene in 
this type of cycloaddition process, we pursued a small model study. We first targeted the 
reaction of ethyl vinyl ether with 115 in the presence of a Ru (II) photocatalyst 
RuCl2(bpy)3.6H2O (Scheme 2.30 (A)) in dry dichloromethane. In lieu of a cycloadduct, we 
isolated a mixture of two compounds, which were attributed to lactol 131 and endoperoxide 
132 by comparison with the work of Tan and coworkers.111 The same outcome was found 
upon using the pyran alone without ethyl vinyl ether in this reaction. In degassed 
dichloromethane, no reaction was observed in the presence of the ruthenium photocatalyst. 
Scheme 2.30 Attempted Radical Cation [4+2] Cycloaddition of 2H-Pyran 115 
 
 
 Unclear to us was the mechanism of this oxidative process. We questioned the role 
of the ruthenium catalyst, whether if it was serving as a photosensitizer generating singlet 
oxygen,158 or if it promoted excitation of the pyran to a diradical,159,160 further trapped by 
triplet oxygen. The ruthenium catalyst has a reported excited state triplet energy of 61 
kcal/mol at its emission maximum (470 nm),161 a value higher than needed to irreversibly 
excite O2 to 
1O2 (37.5 kcal/mol). The first hypothesis was tested by introducing a catalytic 
amount of the singlet oxygen quencher DABCO, and, in this case, no reaction occurred 
(Scheme 2.31 (A)). The second hypothesis proved incorrect, as using the radical scavenger 
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BHT did not inhibit the reaction, and the previously isolated compounds were obtained 
(Scheme 2.31 (B)). In the absence of photocatalyst or light, the photooxygenation of 115 
was not observed, and we recovered the starting material. From these control experiments, 
we believe the ruthenium catalyst only acts a photosensitizer for 1O2 in this reaction. 
Scheme 2.31 Photooxygenation of 2H-Pyran 115: Mechanistic probes 
 
 
The more easily oxidizable trans-anethole 165 (Eox =1.1 V) was chosen to validate 
the hypothesis of 2H-pyran 115 participating in radical cation [4+2] event (Scheme 2.32). 
Using a catalytic amount of triphenyl pyrylium tetrafluoroborate 170 (Eox = 2 V), a known 
promoter of photoinduced single electron transfer,162–164 trans-anethole 165 (Eox = 1.1 V 
in MeCN) reacted with 115 in a [4+2] cycloaddition, yielding adduct 171 in 20% yield. 
The relative configuration for this adduct (endo, trans) was deduced through 2D NMR 
experiments (HSQC, HMBC, NOESY) and careful analysis of the coupling constants of 
the cyclohexene ring. We were pleased with this result, as it may expand our options 
regarding the key cycloaddition event toward swerilactones A and B, outside of a normal 
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demand Diels-Alder reaction. For example, an electron rich, enol ether substituted lactone 
dienophile could be accessed and its reactivity in radical cation cycloaddition with pyran 
115 may be probed. 
Scheme 2.32 Radical Cation Cycloaddition of Trans-Anethole 163 and 2H-Pyran 115 
 
 
2.5 Summary and Conclusion 
Throughout this chapter, we have presented our efforts aimed at the synthesis of 
the core of a lactonized 2H-pyran via a Saucy-Marbet rearrangement, which is meant to 
serve as a diene in our proposed biomimetic synthesis of swerilactones A and B. Contrary 
to the largely documented propensity of 2H-pyrans to self-dimerize or participate in 
hydride shift to form acyl ketene, our targeted pyran was found to be heat sensitive, 
resulting in decomposition. 
We were nonetheless able to explore the preliminary reactivity of this key 
component in Diels-Alder cycloadditions. We have shown that thermal normal demand 
(Section 2.4.2) and radical cation [4+2] (Section 2.4.3) were two accessible modes of 
reactivities for 2H-pyran 115, whereas thermal inverse demand represented a largely 
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unproductive pathway. The following chapter will focus on accessing several lactone 
dienophiles, with an aim to pinpoint the best way of merging the two reaction partners.  
 
2.6 Experimental Section 
General Information: 1H NMR spectra were recorded at 300, 400, or 500 MHz at ambient 
temperature with CDCl3, CD3OD, DMSO-d6 or benzene-d6 (Cambridge Isotope 
Laboratories, Inc.) as solvents. Data for 1H NMR are reported as follows: chemical shift, 
integration, multiplicity (br = broad, ovrlp = overlapping, s = singlet, d = doublet, t = triplet, 
q = quartet, m = multiplet) and coupling constants in Hz. 13C NMR spectra were recorded 
at 100.0, or 125 MHz at ambient temperature with the same solvents unless otherwise 
stated. Chemical shifts are reported in parts per million relative to the deuterated solvents. 
All 13C NMR spectra were recorded with complete proton decoupling. Infrared spectra 
were recorded on a Nicolet Nexus 670 FT-IR spectrophotometer. High-resolution mass 
spectra were obtained in the Boston University Chemical Instrumentation Center using a 
Waters Q-TOF API-US mass spectrometer. Melting points were recorded on a Mel-Temp 
apparatus (Laboratory Devices). Analytical LC-MS was performed on a Waters Acquity 
UPLC (Ultra Performance Liquid Chromatography (Waters MassLynx Version 4.1) with 
a Binary solvent manager, SQ mass spectrometer, Water 2996 PDA (PhotoDiode Array) 
detector, and ELSD (Evaporative Light Scattering Detector). An Acquity UPLC BEH C18 
1.7 μm column was used for analytical UPLC-MS. Optical rotations were recorded on an 
AUTOPOL III digital polarimeter at 589 nm, and specific rotations are given [α]D20 
(concentration in grams/100 mL solvent). SFC analysis of enantioenriched compounds was 
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performed on a Berger SFC (Waters) System with a diode array detector using a SFC 
Chiralcel®OD-H (Chiral Technologies Inc., 100 × 4.6 mm I.D., 5μm) column. Preparative 
HPLC was performed on a Gilson PLC2020 using a Waters SunFire™ Prep C18 OBD™ 
5μm 19X50 mm column. Analytical thin layer chromatography was performed using 0.25 
mm silica gel 60-F plates. Flash chromatography was performed using 200-400 mesh silica 
gel (Scientific Absorbents, Inc.). Yields refer to chromatographically and spectroscopically 
pure materials, unless otherwise stated. HPLC grade tetrahydrofuran, methylene chloride, 
diethyl ether, toluene, acetonitrile, and benzene were purchased from Fisher and VWR and 
were purified and dried by passing through a PURE SOLV® solvent purification system 
(Innovative Technology, Inc.). Other ACS grade solvents for chromatography were 
purchased from Fisher. Select photochemistry experiments were performed using a 
jacketed beaker covered in tape with spiralled blue LEDs strip (hν = 450 nm) on the inside 
walls. A flow of cold water was used to cool the beaker down upon irradiation. All other 
reactions were carried out in oven-dried glassware under an argon atmosphere unless 
otherwise noted. 
 
1,4-Adduct 138: In a 1L flame-dried 3 neck-flask equipped with a 60 mL 
addition funnel under nitrogen, ether (60 mL) was added and the reaction was cooled to -
78 C. (E)-1-Bromoprop-1-ene (3.5 mL, 40.7 mmol, 1.55 equiv.) (volatile) was introduced 
via syringe. A solution of 1.7 M tert-butyllithium in pentane (46.4 mL, 3 equiv.) was added 
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dropwise over 10 min. The walls of the addition funnel were rinsed with a small quantity 
of ether. 
To a separate 200 mL flame-dried Schlenk flask under nitrogen, copper(I) iodide (7.5 g, 
39.4 mmol, 1.5 equiv.) (previously dried with a heat gun under high vacuum) was added 
and the vessel was purged 3 times with a vacuum/nitrogen cycle. At room temperature, 
ether (50 mL) was introduced, followed by freshly distilled tributylphosphine (23.6 mL, 
94.6 mmol, 3.6 equiv.) dropwise. An exotherm developed. The reaction mixture turned 
from a suspension to a clear solution after 5 minutes of vigorous stirring. After 20 min, the 
cuprate solution was cannulated into the addition funnel, and then added over 10 min to 
the vinyl lithium solution at -78 °C. The solution turned from pale yellow to a bright yellow 
slurry and was stirred for 1.5 h at -78 °C. 
2H-Pyran-2-one, 5,6-dihydro- (2.52 mL, 26.3 mmol, 1 equiv.) was added into an addition 
funnel and was dissolved in dry ether (50 mL). This solution was added at -78 °C slowly 
over 60 minutes into the yellow cuprate solution. The walls of the addition funnel were 
rinsed with a small quantity of ether (5 mL). The reaction was stirred for 60 minutes at -78 
°C. TLC showed complete conversion (EtOAc/Hex 3:7, KMnO4 stain). The reaction 
mixture was quenched with saturated NH4Cl (100 mL), extracted with ether (3 x 50 mL), 
and was washed with brine. The ethereal solvent was removed in vacuo using a rotavap 
with a weak pull (Note: the 1,4 adduct was found to be volatile; care was taken to keep the 
water bath cold with ice). The crude oil was then purified on a long height column using a 
gradient of Hexanes/EtOAc (100:0, 95:5, 93:7, 9:1, 88:12, 85:15, 83:17, 4:1, 7:3, 1:1, 
0:100) to yield the desired after careful concentration (weak pull rotavap, cold water bath). 
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The 1,4-adduct was obtained as a colorless, volatile oil. A final weight was obtained by air 
drying the concentrated sample for 10 minutes (13.15 mmol, 1.84 g, 50%). 
Rf = 0.25 (hex/EtOAc 7:3 UV, KMnO4); IR νmax (film): 2970, 2959, 2913, 1736, 1461, 
1441, 1402, 1250, 1217, 1172, 1069, 968 cm-1; 1H NMR (500 MHz, CDCl3)  5.52 (dqd, 
J = 15.5, 6.0, 1.0 Hz, 1H), 5.37 (ddq, J = 15.5, 6.5, 1.5 Hz, 1H), 4.43 (dt, J = 11.5, 4.5 Hz, 
1H), 4.27 (ddd, J = 11.5, 10.0, 3.5 Hz, 1H), 2.68 (ddd, J = 17.0, 6.0, 1.5 Hz, 1H), 2.61 (m, 
1H), 2.32 (dd, J = 17.0, 10.0 Hz, 1H), 1.95 (ddd, J = 13.0, 8.0, 4.5, 1.5 Hz, 1H), 1.68 (ddd, 
J = 6.5, 1.5, 1 Hz, 1H), 1.67 (m, 1H); 13C NMR (126 MHz, CDCl3) δ 170.9, 132.4, 125.8, 
68.3, 36.1, 34.3, 29.0, 17.8; HR-MS: m/z Calcd for [C8H12O2+H]
+ 140.08, found. 
 
Formylated lactone 135: To a 100 mL flame-dried Schlenk flask under 
nitrogen was added freshly distilled N,N-diisopropylamine (0.5 mL, 3.583 mmol, 1.25 
equiv) dissolved in THF (14 mL). A solution of 2.5 M of n-BuLi in hexanes (1.4 mL, 1.2 
equiv.) was added dropwise at -78 C, and flask was transferred to an ice bath. The reaction 
was stirred for 30 minutes at 0 C. 
A solution of 1,4 adduct 137 (400.7 mg, 2.8 mmol, 1 equiv.) in THF (6 mL) was then added 
dropwise at -78 C over 10 minutes, followed by hexamethylphosphoramide (0.99 mL, 5.7 
mmol, 2 equiv.). The flask was transferred to a chiller cooled at -10 °C for 1h. The reaction 
mixture was cooled back to -78 °C before 2,2,2-trifluoroethyl formate (860 μL, 8.8 mmol, 
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3 equiv.) was added via syringe. The reaction was left to warm slowly at 0 °C in a chiller 
overnight.  
The crude mixture was quenched with ammonium chloride and aqueous HCl. Water and 
ether were added; the organic phase was separated and the water layer was extracted with 
ether (3x). The organic layer was then washed with 10% aqueous NaOH (3x). The basic 
aqueous layer was further reacidified at 0 °C with 2N HCl until pH 3 was reached. 
Extraction of the acidified aqueous layer with methylene chloride (3x) was followed by 
drying and concentration in vacuo to yield a crude oil. Purification on silica gel (ethyl 
acetate/hexanes (slow gradient from 5% to 30%)) afforded the desired formylated lactone 
as an orange oil. 
Rf = 0.33 (hex/EtOAc, 7:3, UV, KMnO4); IR νmax (film): 2963, 2919, 2857, 2764, 1656, 
1604, 1476, 1417, 1372, 1340, 1272, 1226, 1124, 1068, 965, 857, 775, 720  cm-1; 1H NMR 
(500 MHz, CDCl3)  12.58 (d, J = 16.0 Hz, 1H), 7.16 (d, J =16.0 Hz, 1H), 5.5 (dd, J = 
18.0, 8.0 Hz, 1H), 5.3 (dd, J = 18.0, 8.0 Hz, 1H), 4.35 (m, 1H), 4.25 (m, 1H), 3.15 (m, 1H), 
1.95 (m, 1H), 1.75 (m, 1H), 1.73 (d, J = 8.0 Hz, 3H); 13C NMR (100 MHz, CDCl3)  171.7, 
165.5, 132.0, 128.3, 100.9, 66.8, 36.7, 29.2, 17.7; HR-MS: m/z Calcd for [C9H12O3+H]
+ 
168.08, found 
 
5/6 fused lactone 141: In a thick wall microwave vial, formylated lactone 135 
(122.0 mg, 725.4 μmol, 1 equiv.), palladium acetate (16.3 mg, 72.5 μmol, 10 mol%), and 
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diphenyl-[(2S)-pyrrolidin-2-yl]methanol (36.8 mg, 145.1 μmol, 20 mol%) were dissolved 
in wet DMSO (2.7 mL). Oxygen was then bubbled through the reaction for 30 minutes 
using an attached balloon after which time the vial was transferred to a preheated oil bath 
at 70°C and stirred at this temperature for 12 h. TLC showed incomplete conversion. Direct 
loading of the crude on silica (EtOAc in hexanes, slow gradient 3%, 5%, 10%, 15%, 20%, 
22%) yielded partial separation of the two diastereoisomers. The diastereomeric mixture 
was separated using prep TLC (Hex/EtOAc 88:12) to yield the two diastereomers 141a and 
141b as colorless oils. 
Major (cis) 5/6 fused lactone diastereoisomer 141a: 
Rf = 0.47(hex/EtOAc, 3:2 UV, KMnO4); IR νmax (film): 2992, 2952, 2932, 2884, 2857, 
1718, 1645, 1625, 1131, 1064, 835, 777 cm-1; 1H NMR (500 MHz, CDCl3)  7.36 (d, J = 
2.0 Hz, 1H), 6.05 (ddd, J = 17.5, 10.5, 7.0 Hz, 1H), 5.4 (dd, J = 17.5, 1.0 Hz, 1H), 5.353 
(dd, J = 10.5, 1.0 Hz, 1H), 4.86 (dd, J = 12.0, 7.0 Hz 1H), 4.50 (ddd, J = 12.0, 4.5, 2.5 Hz, 
1H), 4.23 (ddd, J = 12.0, 12.0, 2.5 Hz, 1H), 3.14 (dddd, J = 12.0, 12.0, 4.5, 2.5 Hz, 1H), 
2.06 (dddd, J = 12.0, 4.5, 2.5, 2.5 Hz, 1H), 1.85 (dddd, J = 12.0, 12.0, 12.0, 4.5 Hz, 1H); 
13C NMR (126 MHz, CDCl3) δ 162.5, 157.2, 134.5, 119.6, 108.0, 93.758, 68.8, 44.1, 27.9.; 
HR-MS: m/z Calcd for [C9H10O3+H]
+ 167.0708, found 167.0712. 
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Minor (trans) 5/6 fused lactone diastereoisomer 141b: 
Rf = 0.41 (hex/EtOAc, 3:2 UV, KMnO4); IR νmax (film): 2992, 2952, 2932, 2884, 2857, 
1718, 1645, 1625, 1131, 1064, 835, 777 cm-1; 1H NMR (500 MHz, CDCl3)  7.38 (d, J = 
2.5 Hz, 1H), 5.78 (ddd, J = 17.5, 10.5, 7.0 Hz, 1H), 5.40 (dd, J = 10.5, 7.0 Hz, 1H), 5.32 
(dd, J = 17.5, 7.0 Hz, 1H), 5.30 (dd, J = 10.5, 1.0 Hz, 1H), 1H), 4.85 (ddd, J = 12.0, 5.0, 
2.5 Hz, 1H), 4.23 (ddd, J = 12.0, 12.0, 2.5 Hz, 1H), 3.49 (dddd, J = 12.0, 10.5, 5.0, 2.5 Hz, 
1H), 1.89 (dddd, J = 12.0, 5.0, 2.5, 2.5 Hz, 1H),), 1.79 (dddd, J = 12.0, 12.0, 12.0, 5.0 Hz, 
1H); 13C NMR (126 MHz, CDCl3) δ 163.3, 156.6, 131.7, 118.6, 88.5, 68.9, 41.2, 25.0.; 
HR-MS: m/z Calcd for [C9H10O3+H, ]
+ 167.0708, found 167.0714. 
Transesterification product 145: To a flame-dried 100 mL round bottom 
flask mounted with a water condenser was added (E)-hex-4-ene-1,3-diol (947.33 mg, 1.72 
mmol, 2.4 equiv.) and methyl 3,3-dimethoxypropanoate (500 mg, 3.37 mmol, 1 equiv.) 
dissolved in toluene (30 mL). The reaction mixture was heated at reflux (110 °C) for 48 hr. 
The reaction was found incomplete by TLC analysis (Hexanes/EtOAC 75:25, CAM stain). 
Nonetheless, the crude was concentrated in vacuo and was directly purified on silica gel 
(Hexanes/EtOAc 100:0, 9:1, 85:15, 8:2, 7:3, 6:4, 1:1, 0:100). The desired compound 145 
was isolated as a clear oil (284.0 mg, 1.22 mmol, 36%). Rf = 0.19 (hex/EtOAc, 7:3, 
KMnO4); IR νmax (film): 3487, 3470, 3441, 3405, 2971, 2940, 2917, 2833, 1737, 1452, 
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1380, 1313, 1257, 1169, 1117, 1056, 967, 921, 830 cm-1; 1H NMR (500 MHz, CDCl3)  
5.69 (dqd, J = 15.0, 6.5, 1 Hz, 1H), 5.49 (d, J = 15.0, 7.0, 1.5 1H), 4.82 (t, J = 6.0 Hz, 1H), 
4.30 (m, 1H), 4.15 (m, 1H), 3.36 (s, 6H), 2.65 (d, J = 6.0 Hz, 1H), 1.88 (d, J = 4.0 Hz, 1H), 
1.84 (J = 6.5 Hz, 1H, AB system), 1.84 (J = 6.5 Hz, 1H, AB system), 1.69 (ddd, J = 6.5, 
1.5, 1.0 Hz, 3H); 13C NMR (126 MHz, CDCl3) δ 169.9, 133.4, 126.9, 101.16, 69.47, 61.67, 
53.3 (3C), 53.3 (3C), 38.8, 36.0, 17.5.; HR-MS: m/z Calcd for [C11H20O5+Na]
+ 255.1208, 
found 255.1203. 
 
 Enone 142: In a 100 mL round bottom flask under argon, transesterification 
product 144 (581.20 mg, 2.50 mmol. 1 equiv.) was dissolved in CH2Cl2 (20 mL) and water 
(90.1 mg, 5.0 mmol, 2 equiv). Dess Martin periodinane (1.59 g, 3.75 mmol, 1.5 equiv.) 
was added at room temperature. TLC after 60 minutes showed almost complete conversion. 
0.2 additional equiv. of DMP were introduced. After 15 minutes, the reaction was found to 
be complete by TLC analysis (hexanes/EtOAc 7:3, CAM stain). Reaction was quenched 
with sodium bicarbonate (20 ml), saturated Na2S2O3 (20 mL), then extracted with CH2Cl2 
(3x40 mL), and was finally washed with brine. The organic extracts were dried over 
sodium sulfate, filtered, and concentrated in vacuo. Purification on silica gel 
(hexanes/EtOAc 95:5, 9:1, 4:1, 7:3, 6:4, 1:1) yielded the desired product 142 (457 mg, 1.98 
mmol, 79%) as a colorless oil. Rf = 0.25 (hex/EtOAc, 7:3, KMnO4); IR νmax (film): 2959, 
2909, 2835, 1736, 1674, 1631, 1443, 1379, 1314, 1255, 1190, 1170, 1116, 1054, 1021, 
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921, 839 cm-1; 1H NMR (500 MHz, CDCl3)  6.88 (dq, J = 15.5, 7.0 Hz, 1H), 6.14 (dq, J 
= 15.5, 1.5 Hz, 1H), 4.80 (t, J = 6.0 Hz, 1H), 4.41 (t, J = 6.5 Hz, 2H), 3.35 (s, 6H), 2.88 (t, 
J = 6.5 Hz, 2H), 2.63 (d, J = 6.0 Hz, 2H), 1.92 (dd, J = 7.0, 1.5 Hz, 3H); 13C NMR (126 
MHz, CDCl3) δ 196.7, 169.6, 143.6, 131.8, 101.1, 59.7 (2C), 53.4, 38.7, 38.2, 18.2;HR-
MS: m/z Calcd for [C11H18O5+Na]
+ 253.1052, found 253.1051. 
 
TBS-protected propargyl vinyl ether 152. Adapted from a 
literature procedure:165 To a flame-dried 50 mL round bottom 
flask under argon, 6-[tert-butyl(dimethyl)silyl]oxyhex-3-yn-2-
ol136 (346.2 mg, 1.5 mmol, 1 equiv.) was added which was followed by addition of dry 
CH2Cl2 (12 mL). At room temperature, methyl prop-2-ynoate (127.8 mg, 1.5 mmol, 135 
μL, 1 equiv.) was introduced, which was immediately followed by tributylphosphine (61.5 
mg, 304.0 umol, 75 L, 0.2 equiv.). The reaction turned red and was left stirring at room 
temperature for 12 h. TLC (Hex/EtOAc 85:15, KMnO4) and crude 
1H NMR analysis 
showed complete conversion of the starting alcohol. The reaction was concentrated in 
vacuo and was purified on silica gel (Hex/EtOAc 98:2, 95:5, 9:1, 8:2) to yield the desired 
vinyl ether 152 (448 mg, 1.4 mmol, 94%) as a colorless oil. Rf = 0.24 (hex/EtOAc 95:5, 
UV, KMnO4); IR νmax (film): 2992, 2952, 2932, 2884, 2857, 1718, 1645, 1625, 1131, 
1064, 835, 777 cm-1; 1H NMR (500 MHz, CDCl3)  7.59 (d, J = 12.5 Hz, 1H), 5.35 (d, J 
= 12.5, 1H), 4.66 (qt, J = 6.5, 2 Hz, 1H), 3.71 (t, J = 7.0 Hz, 2H), 3.70 (s, 3H), 2.43 (td, J 
= 7.0, 2.0 Hz, 2H), 1.5 (d, J = 6.5 Hz, 3H), 0.89 (s, 9H), 0.07 (s, 6H); 13C NMR (100 MHz, 
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CDCl3)  168.1, 160.4, 98.3, 85.2, 78.5, 67.9, 61.5, 51.0, 25.8 (3C), 23.0, 22.1, 18.3, -5.3 
(2C); HR-MS: m/z Calcd for [C16H28O4Si+H]
+ 313.1835, found 313.1834. 
 
TBS-protected 2H-pyran 153. To a 10 mL round bottom flask 
flame-dried under argon, methyl (E)-3-[5-[tert-
butyl(dimethyl)silyl]oxy-1-methyl-pent-2-ynoxy]prop-2-enoate 151 (104.0 mg, 332.8 
μmol, 1 equiv.) was dissolved in dry CH2Cl2 (2 mL). Gold (I) chloride (5.05 mg, 16.64 
μmol, 5 mol%, obtained from Strem) was added, and the reaction was heated at 30 °C for 
2.5 h after which time TLC analysis showed complete conversion and crude 1H NMR 
analysis of an aliquot showed full conversion to the allene intermediate 153. 
At room temperature, DBU (2.5 mg, 16.6 μmol, 2.5 μL, 5 mol%) was added to the reaction 
mixture in one portion. The reaction was stirred for 3 hours, after which time 1H NMR of 
an aliquot showed complete conversion from the allene to the 2H-pyran. The crude product 
was directly concentrated and purified on silica gel (Hex/EtOAc 97:3, 95:5, 90:10) to 
afford the desired product 153 as a colorless oil (78 mg, 249.6 mmol, 75%). This compound 
was found to decompose upon storage on the benchtop overnight, but could be stored for 
longer periods in a -20 °C or -40 °C freezer. Rf = 0.35 (Hex/EtOAc 95:5, UV, KMnO4); 
IR νmax (film): 3025, 2983, 2969, 2928, 2891, 2859, 1716, 1437, 1256, 1099, 835, 776 
cm-1; 1H NMR (500 MHz, CDCl3)  7.44 (s, 1H), 5.06 (ddd overlap, J = 1.5, 1.5, 1.0 Hz, 
1H), 4.82 (, J = 6.5, 1.0 Hz, 1H), 3.70 (s, 3H), 3.66 (t, J = 6.5 Hz, 2H), 2.68 (qt app, J = 
6.5, 6.5, 7.0, 1.5 Hz , 1H, AB system), 2.61 (qt app, J = 6.5, 6.5, 7.0, 1.5 Hz , 1H, AB 
system), 1.39 (d, J = 6.5 Hz); 13C NMR (125 MHz, CDCl3)  166.1, 157.1, 130.1, 118.1, 
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109.1, 73.3, 62.4, 51.0, 36.1, 25.9(2C), 20.6, 18.3, -5.3(3C); HR-MS: m/z Calcd for 
[C16H28O4Si+H]
+ 313.1835, found 313.1835. 
 
Cycloadduct 162: In a flame-dried thick wall microwave vial under 
nitrogen, methyl vinyl ketone (8.4 mg, 120.4 μmol, 1 equiv.) and 2H-pyran 115 (20.0 mg, 
120.4 μmol, 1 equiv.) were dissolved in anhydrous toluene (2 mL) and heated overnight at 
90°C for 12 h. Concentration in vacuo followed by purification on silica gel 
(hexanes/EtOAc, 95:5, 9:1, 8:2, 3:7, 4:6, 1:1, 3:7, 0:100) yielded the cycloadduct 162 as 
an oil (28.3 mg, 46.6 μmol, 38%, endo/exo dr 4:1 by 1H NMR,). The endo structure of the 
major product was confirmed by 2D NMR analysis (COSY, 13C, HSQC, HMBC, NOESY). 
Rf = 0.08 (Hex/EtOAc 1:1, UV, KMnO4); IR νmax (film): 2968, 2927, 2871, 1708, 1466, 
1414, 1375, 1361, 1279, 1268, 1248, 1203, 1174, 1152, 1107, 1077, 1010, 968, 907 cm-1; 
1H NMR (500 MHz, CDCl3)  5.21 (d, J = 3 Hz, 1H), 4.43 (m, 2H), 4.01 (qd, J = 6, 1.5 
Hz, 1H), 3.34 (m, 1H), 2.70 (ddd, J = 14 Hz, 1H, AB system), AB system, 4.00 (m, 1H), 
3.34 (m, 1H), 2.71 (qd, J = 18.5, 7, 5.5 Hz, 1H), 2.68 (m, 1H), 2.49(ddd, J = 18.5, 7, 5.5 
Hz, 1H), 2.23 (s, 3H), 2.08 (ddd, J = 13, 5, 3 Hz, 1H), 1.72 (ddd, J = 13, 9, 3 Hz, 1H),  0.95 
(d, J = 6 Hz, 1H) ; 13C NMR (125 MHz, CDCl3) 205.5, 161.0, 158.2, 127.4, 71.7, 66.4, 
65.1, 51.7, 40.9, 29.3, 27.5, 23.5, 21.6; HR-MS: m/z Calcd for [C13H16O4+H]
+ 237.1049, 
found . 
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Cycloadduct 163: In a flame-dried thick wall microwave vial under 
nitrogen, 1-benzylpyrrole-2,5-dione (33.79 mg, 180.54 mol, 1 equiv.) and 2H-pyran 115 
(30.00 mg, 180.54 mol, 1 equiv.) were dissolved in anhydrous toluene (2 mL) and heated 
at 90 °C for 12 h. Concentration in vacuo followed by purification on silica gel 
(hexanes/EtOAc, 95:5, 9:1, 8:2, 3:7, 4:6, 1:1, 3:7, 0:100) yielded the cycloadduct 163 as 
an amorphous solid (22.5 mg, 63.7 μmol, 35%, endo/exo dr 6:1 by 1H NMR). The endo 
structure of the major product was confirmed by 2D NMR analysis (COSY, 13C, HSQC, 
HMBC, NOESY). Rf = 0.10 (Hex/EtOAc 1:1, UV, KMnO4); IR νmax (film): 2955, 2925, 
2853, 1773, 1700, 1604, 1496, 1466, 1412, 1396, 1345, 1280, 1172, 1152, 1076, 909, 733 
cm-1; 1H NMR (500 MHz, C6D6)  7.29 (dd, J = 7.5, 1.0 Hz, 2H), 7.03 (dd, J = 7.5, 7.5 
Hz, 2H), 6.96 (dd, J = 7.5, 1.0 Hz, 1H), 5.45 (d, J = 4.5 Hz, 1H), 4.33 (d, J = 14 Hz, 1H, 
AB system), 3.99 (d, J = 14 Hz , 1H, AB system), 3.30 (m, 1H), 3.24 (qd, J = 6.5, 1.0 Hz, 
1H), 2.72 (dd, J = 8.0, 4.5 Hz, 1H), 2.68 (m, 1H), 2.31(dd, J = 4.0, 1.0 Hz, 1H), 2.07 (dd, 
J = 8.0, 4.0 Hz, 1H), 1.30 (m, 2H), 0.42 (d, J = 6.5 Hz, 3H); 13C NMR (125 MHz, CDCl3) 
176.1, 173.8, 159.4, 154.4, 135.7, 129.2 (2C), 128.9 (2C), 128.3, 128.3, 70.0, 65.3, 64.3, 
44.4, 42.5, 42.2, 40.4, 27.7, 21.0.; HR-MS: m/z Calcd for [C20H19O5N+H]
+ 354.1263, 
found 354.1267. 
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Cycloadduct 164: In a flame-dried thick wall microwave vial 
under nitrogen, 1-(4-bromophenyl)pyrrole-2,5-dione (62.6 mg, 248.4 μmol, 1.2 equiv.) and 
2H-pyran 115 (34.4 mg, 207.0 μmol, 1 equiv.) were dissolved in toluene (2 mL) and heated 
at 90 °C for 12 h. Concentration in vacuo followed by purification on silica gel 
(hexanes/EtOAc, 95:5, 9:1, 8:2, 3:7, 4:6, 1:1, 3:7, 0:100) yielded the cycloadduct 164 as 
an amorphous solid-oil (29.7 mg, 71 μmol, 34%, endo/exo dr 10:1 by 1H NMR). The endo 
structure of the major product was confirmed by 2D NMR analysis (COSY, 13C, HSQC, 
HMBC, NOESY). Rf = 0.24 (Hex/EtOAc 3:2, UV, KMnO4); IR νmax (film): 3482, 3058, 
2971, 2902, 1779, 1713, 1490, 1412, 1381, 1278,1224, 1182, 1152, 1037, 815, 774, 734 
cm-1; 1H NMR (500 MHz, CDCl3)  7.56 (d, J = 9.0 Hz, 2H), 7.00 (d, J = 9.0 Hz, 2H), 
5.39 (d, J = 4.5 Hz, 1H), 4.46 (ddd, J = 7.0, 5.5, 5.5 Hz , 1H, AB system), 4.27 (ddd, J = 
7.0, 5.5, 5.5 Hz, 1H, AB system) 4.11 (qd, J = 6.0, 1 Hz, 1H), 3.65 (dd, J = 8.0, 4.5 Hz, 
1H), 3.38 (dd, J = 8.0, 3.5 Hz, 1H) 3.36 (dd, J = 3.5, 1.0 Hz, 1H), 2.56 (ddd, J = 7.0, 5.5, 
5.5 Hz, 1H), 2.53 (ddd, J = 7.0, 5.5, 5.5 Hz, 1H), 1.06 (d, J = 6.0 Hz, 3H); 13C NMR (101 
MHz, CDCl3) 175.2, 172.6, 159.6, 155.3, 132.5, 132.4 (2C), 130.1, 127.3 (2C), 122.8, 
70.1, 66.2, 64.7, 44.5, 42.4, 41.1, 28.3, 21.2.; HR-MS: m/z Calcd for [C20H19O4N+H]
+ 
418.0212, found 418.0294 
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Radical Cation Cycloadduct 171: In a 10 mL Schlenk flask under 
nitrogen in the dark, trans-anethole (10.0 mg, 67.5 μmol, 10 μL, 1 equiv.), 2H-pyran 115111 
(33.6 mg, 202.4 umol, 3 equiv.), and 2,4,6-triphenylpyrylium tetrafluoroborate (1.3 mg, 
3.5 μmol, 5 mol%) were introduced. Dry, thoroughly degassed CH2Cl2 (1.5 mL) (via 
freeze-pump-thaw cycle 3 times) was added and the flask was irradiated at 450 nm (Blue 
LEDs) in a water cooled jacketed beaker at room temperature for 12 h. TLC analysis 
(EtOAc/hexanes. 25:75) showed the presence of 4 new products, and complete 
consumption of trans-anethole. The crude was concentrated and carefully purified on silica 
gel (hex/EtOAc 9:1, 4:1, 7:3, 3:2, 1:1, 2:3, 3, 7, 0:100) to afford the desired cycloadduct (5 
mg, 15.9 mol, 23%) as a yellow oil. 
Rf = 0.22 (hex/EtOAc 1:1, UV, KMnO4); IR νmax (film): 3965, 2931, 1716, 1611, 1513, 
1464, 1410, 1247, 1180, 1035, 994, 811 cm-1; 1H NMR (500 MHz, CDCl3) δ 6.93 (d, J = 
9.0 Hz, 2H), 6.78 (d, J = 9.0 Hz, 2H), 4.73 (d, J = 2.0 Hz, 1H), 4.53 (m, 1H), 4.37 (q, J = 
6.0 Hz, 1H), 3.75 (s, 3H), 2.87 (dd, J = 7.0, 2.0 Hz,1H), 2.83 (dt, J = 6.0, 18.0 Hz,1H), 2.61 
(dt, J = 18.0, 6.0 Hz,1H ), 2.42 (s app, 1H), 1.86 (qdd, J = 7.0, 7.0, 2.0 Hz, 1H), 1.25 (d, J 
= 7.0 Hz, 3H), 1.00 (d, J = 6.0 Hz, 3H); 13C NMR (125 MHz, CDCl3) δ 161.3, 159.2, 
158.4, 133.0, 128.6, 128.4, 114.0, 69.5, 66.3, 64.5, 55.2, 51.8, 48.3, 37.6, 27.9, 21.6, 16.7. 
HR-MS: m/z Calcd for [C19H22O4+H]
+ 315.1586, found 315.1589.  
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Selected Spectra 
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Key NOESY Correlations for Endo Adduct 163 
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Key HMBC Correlations for Endo Adduct 163 
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Key NOESY Correlations for Cycloadduct 171 
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Key NOESY Correlations for Cycloadduct 171 
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CHAPTER 3                                                                                                                   
Preparation of Substituted Lactone Dienophiles and Studies toward a 
Biomimetic Synthesis of Swerilactones A and B 
3.1 Introduction 
 The reactivity of both 2H-pyran diene 115 and the enol 114 or ketene precursor 122 
at the outset of our studies was unknown, and thus, the feasibility of the [4+2] cycloaddition 
was an open question (Figure 3.1 for our proposed Diels-Alder cycloaddition approaches).  
Figure 3.1 Proposed Cycloadditions of Pyran 115 with Ketene and Enol Dienophiles 
 
 
We planned to target a variety of dienophiles for the key formal Diels-Alder cycloaddition 
to increase our chance of finding an ideal substrate for this reaction (Figure 3.2 for 
representative lactone dienophiles). 
Figure 3.2 Planned Dienophilic Lactones  
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 We conceived a viable synthetic pathway en route to several lactone-containing 
dienophiles with an enol or aldehyde functional group at the 4-position such as 114 or 122, 
which would be derived from cross-coupling of β-halogenated sorbate 172 with α-
stannylated acrylate derivatives such as 173 (Scheme 3.1). Diene 172 was envisioned to 
arise from two pathways: direct C-H halogenation of sorbic acid 174 or stepwise cross-
coupling of gem-dibromoolefin 175 with propenyl metal reagents 176. 
Scheme 3.1 Retrosynthesis of Substituted Lactone Dienophiles: A Unified Strategy 
 
 
3.2 En route to Lactone Dienophiles: Synthesis of a Key β-Bromo Sorbate 
Derivative 
3.2.1 First Synthetic Route: C-H Activation of Sorbic Acid and Derivatives 
 The field of C-H activation has greatly expanded over the last several years in terms 
of scope and application of many directing groups. A large focus of the area is centered on 
C-H activation of benzoate derivatives166 and heterocyclic compounds. Prof. Yu and 
coworkers have pioneered efforts in the C-H halogenation of benzoates using a carboxylate 
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functionality as a directing group.167,168 They demonstrated successful C-H iodination of 
simple benzoates in the presence of Pd(II) and iodonium acetate (Scheme 3.2 (A)).169 Due 
to their prevalence in medicinal chemistry and synthetic versatility, aryl halides have been 
targeted by many research groups, and C-H halogenations have been reported using a range 
of directing groups and metal catalysts including Pd(II),170–174 Rh(III),175–179 Ru(II),180,181 
Cu(II),171 and Co(III).182 
In contrast, vinylic C-H activations are less precedented183 and tend to rely on 
stronger amide directing groups, potentially due to an increased rotational freedom and 
decreased electron density of vinylic C-H bonds versus aryl C-H bonds. Babu and 
coworkers demonstrated the successful C-H arylation of acrylamides (Scheme 3.2 (B)).184 
The Glorius group has shown examples of C-H halogenation of vinyl amides179 along with 
the C-H alkynylation of diisopropyl amide protected sorbate and cinnamates;185 the latter 
efficiently proceeding in the presence of Rh(III) and excess 1-[(triisopropylsilyl)ethynyl]-
1,2-benziodoxol-3(1H)-one (TIPS-EBX) (Scheme 3.2 (C)). 
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Scheme 3.2 Literature Examples of C-H activation of Benzoates and Vinylogous Amides 
 
 
 With β-C-H activation of sorbates and derivatives being fairly restricted,185 a broad 
C-H activation screen (>70 conditions total) was conducted on intermediate 174 and its 
derivatives (representative conditions are shown in Table 3.1). Different directing groups 
were implemented, ranging from a simple carboxylic acid to the more strongly 
coordinating diisopropyl,179,185 bidendate PIP ((2-pyridine-2-yl)isopropyl) and 8-
aminoquinoline amides, which have been widely used in C-H activation.186–188 A variety 
of metals known to induce C-H activation/halogenation were investigated (as Pd(II), 
Rh(III), and Ru(II)), common additives known to participate in the C-H activation (CsOAc, 
NaHCO3, PivOH, p-TSA), and external oxidants (Cu(OAc)2, Na2S2O8) were evaluated. 
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Disappointingly, regardless of the directing group, metal, additive, halogen source or 
solvent used, we were unable to convert efficiently the sorbate starting material to its 
desired C-H halogenated product. Either extremely low conversion (Table 3.1, entry 1, 3 
and 4), or decomposition was observed (Table 3.1, entry 2). In the case of an arylated 
directing group such as 8-aminoquinoline 174d, the reaction suffered from iodination on 
the heteroaromatic ring instead of the vinylic position (Table 3.1, entry 5), a known side-
reaction of this directing group.189  
Table 3.1 C-H Activation Studies on Sorbic Acid and Derivatives: Representative Conditionsa 
 
a Reactions run on a 10-20 mg scale under an atmosphere of air or argon. Conversion was assessed by crude 1H NMR. 
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3.2.2 Second Synthetic Route: Stepwise Cross-Couplings of a Gem-Dibromolefin 
Failed attempts at inducing a direct C-H halogenation of sorbate derivatives 
prompted a switch in strategy with an emphasis to examine and develop a stepwise pathway 
towards bromo sorbate 172 (Scheme 3.3). In this regard, starting from di-tert-butyl tartrate 
178,190 oxidative cleavage afforded the corresponding tert-butyl glyoxylate as a mixture of 
hydrated and dehydrated forms,191 which upon distillation over P2O5 dessicant was directly 
used in a Ramirez olefination.192 The key gem-dibromoolefin 175 could be obtained on 
gram scale. Cross-coupling with a metallated propenyl species (176) was subsequently 
attempted. 
 Both Suzuki coupling of 175 with the propenyl potassium tetrafluoroborate 
salt of 176 and Stille coupling with stannylated 176193 were studied under a variety of 
conditions (Scheme 3.3). Despite reports by Molander and coworkers regarding highly 
stereoselective Suzuki cross-coupling of 1,1-dibromoalkenes with 
alkenyltrifluoroborates,194 the Stille coupling performed far better in terms of conversion 
and selectivity as only minimal amounts of (E,E)-propenylated 172 and di-propenylated 
side-products were observed by 1H NMR analysis (<15%, Scheme 3.3, entry 4 and 5). A 
substoichiometric amount of copper iodide was found to increase the reaction rate (Scheme 
3.3, entry 5 vs. entry 4), an effect seen in other literature reports.195 These optimized 
conditions proved robust and scalable, yielding gram quantities of the desired tert-butyl 
bromosorbate (Z,E)-172. Of note, similar cross-coupling screens were attempted with 
methyl and ethyl ester protected β-brominated sorbates, but the higher steric crowding 
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imparted by the tert-butyl ester version of 172 correlated with enhanced stereoselectivities 
for the cross-coupling. 
Scheme 3.3 Elaboration of tert-butyl Bromo Sorbate 172 via Stepwise Cross-Couplings 
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3.3 Synthesis of Ester and Enol Substituted Lactones via Oxa-6π 
Electrocyclization 
3.3.1 Access to Ester Substituted Lactones Dienophiles 
 According to our retrosynthetic analysis involving a ketene dienophile (Chapter 2, 
Scheme 2.5), a precursor such as carboxylic acid substituted lactone 122 is required.  The 
key β-bromo sorbate 172 was cross-coupled with α-stannylated methyl acrylate 179196 in 
the presence of catalytic Pd(PPh3)4 and CuI (Scheme 3.4). The reaction was found to 
proceed efficiently on gram scale, generating the full carbon containing framework (Z,E)-
180, with a small amount of (E,E) isomerization byproduct (<10%). Tert-butyl ester 
deprotection was carried out using TFA to afford a mixture of deprotected, ring-opened 
compound 181 along with the lactone product 182. The open form 181 was further cyclized 
in moderate yield to 182. With methyl ester substituted lactone 182 in hand, we were able 
to induce ester deprotection by dealkylation using excess MgI2 
197,198 to the free carboxylate 
substituted lactone 122. 
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Scheme 3.4 Synthesis of Carboxylic Acid-Substituted Lactone 122 
 
 
3.3.2 Access to Enol-Substituted Lactone Dienophiles 
In addition to ketene precursor 122, we remained interested in synthesizing a free 
enol or an enol ether substituted lactone 114. The gram scale synthesis of sorbate 172 
enabled us to further investigate Stille cross-coupling with α-stannylated alcohol 183196,199 
(Table 3.2), which could potentially generate compound 184, a substrate well suited for 
further oxidation and annulation to enol 114. As expected, a prominent side reaction in this 
coupling under mild heating was the lactonization of compound 184 to produce lactone 
185 (Table 3.2, entry 1 and 2). Switching from Pd(PPh3)4 to a more electrophilic and 
reactive source of palladium such as [Pd(allyl)Cl]2 (Table 3.2, entry 3) did not result in 
improvement of the ratio of 184 to 185. Reaction conditions reported to effect Stille 
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coupling of unactivated Csp3-X bond at room temperature200–202 (Table 3.2, entry 4, 5, 6) 
were also met with limited success. The stereochemistry of the desired allylic alcohol 184 
was assigned by NOESY experiments, demonstrating retention of configuration during the 
cross-coupling process. 
Table 3.2 Stille Coupling of Sorbate 172 with α-Stannylated Alcohol 184 
 
 
 Looking to overcome the poor selectivity in the Stille cross-coupling with 
stannylated alcohol 183, we reasoned that adjusting the substitution and oxidation level of 
the stannylated acrylate coupling partner may provide a better outcome (Scheme 3.5). 
 First, by masking 183 as TBS-protected alcohol 186, we obtained a TBS-protected 
coupling product of unknown alkene stereochemistry in good yield (Scheme 3.5 (A)), and 
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upon TBAF treatment, we isolated the isomer of alcohol (Z,E)- 184 (E,E-184). We 
presumed E/Z isomerization of the alkenyl bromide moiety occurred during the cross-
coupling step, as E/Z isomerization is also a step reaction we observed in the cross-coupling 
of 172 with stannylated methyl acrylate 179 (Scheme 3.4). This hypothesis was confirmed 
by sequential TBS protection of (Z,E)-184, followed by TBAF desilylation. We obtained 
the starting (Z,E-184), without production of (E,E-184). We believe the steric repulsion 
imparted by the tert-butyl group, which worked in our favor in the selective cross-coupling 
to (Z,E)-172, is responsible for the observed isomerization around the vinylic C-Pd bond 
to 187 (Scheme 3(B) and 3(C) for two potential mechanistic hypothesis). Similar to our 
reaction screen of stannylated alcohol 183 (Table 3.2), examination of reaction conditions, 
including several sources of Pd(0), ligands and temperature did not change the reaction 
outcome. Triethylsilyl (TES) and trimethylsily (TMS) protected allylic alcohols were also 
evaluated as reaction partners in the cross-coupling, but these protecting groups tended to 
be labile, falling off during the reaction, and still afforded a large amount of E/Z 
isomerization.  
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Scheme 3.5 Stille Coupling with Silyl Protected Alcohol 186 and Potential Isomerization Mechanisms 
 
 
The oxidation state of the stannane partner was further adjusted to the 
corresponding aldehyde. Acrylate 188196,199 polymerized readily under the reaction 
conditions, yielding intermediate 189 in low yield (Scheme 3.5 (A)). The resolution of 
these issues came by employing diethyl acetal-protected aldehyde 190. This stannane, 
under the usual coupling conditions, generated the retentive cross-coupling compound 191, 
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along with a minor amount of isomerization side product (10%) and deprotected aldehyde 
coupling product 189 (5%) (Scheme 3.5 (B)). 
Scheme 3.6 Stille Coupling with Stannylated Acrylates  
 
 
 With a reliable route to protected cross-coupling product 191, the annulation to 
form the six membered-ring lactone core became our next focus. Direct treatment of diethyl 
acetal 191 with TFA, anticipated to result in  global deprotection of both the tert-butyl ester 
and the acetal, instead afforded the lactone-acetal 192 (Scheme 3.7 (A)). A literature report 
had demonstrated opening of a related hemiacetal to a regioisomeric enol form under basic 
conditions (Scheme 3.7 (B)).203 Accordingly, we hoped that compound 192 could be 
similarly rearranged to the desired enol structure 114. Several deprotection conditions were 
tried (acidic and basic), but all unfortunately triggered decomposition of starting material 
192. 
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Scheme 3.7 Attempted Synthesis of Free Enol 114 from Lactone Hemiacetal 192 
 
 
 Stepwise deprotection proved more efficacious, as submission of 191 to aqueous 
HCl under mild heating cleanly promoted formation of acrylate 189 (Scheme 3.8). TFA 
cleavage was then evaluated, producing the non-lactonized carboxylic acid 193 in 
moderate yield. Surprisingly, under thermal heating or microwave irradiation, this 
compound did not cyclize via oxa-6π electrocyclization to enol 114, and 193 was 
recovered. Lewis acid conditions (TMSOTf) also failed, immediately decomposing the 
uncyclized carboxylate 193. 
Scheme 3.8 Stepwise Deprotection Studies to Free Enol 114 
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We then explored the possibility of a simultaneous tert-butyl deprotection/oxa-6π 
electrocyclization mediated by Lewis acids in order to target a substituted enol ether instead 
of a free, enol lactone such as 114, which may potentially be unstable and prone to 
polymerization. Silyl triflates have been reported to cleave tert-butyl esters selectively, 
generating the corresponding carboxylates via intermediacy of a silyl ester.204 In our case, 
employing 2,6-lutidine buffered TBSOTf conditions on 189, we observed a clean 
conversion by TLC to afford what is likely the deprotected ester. However, upon a variety 
of work-up conditions (pH 7 buffer, 1N HCl, lutidine.TfOH salt precipitation) we could 
not isolate TBS-protected enol 114a or the free enol 114 (Scheme 3.9). Switching to 
substoichiometric amount of TMSOTf, we were surprised to isolate the tert-butyl protected 
enol 114b as a single isomer. However, the reaction to produce 114b was difficult to 
reproduce and consequently only 1H NMR data was available. 
Scheme 3.9 Attempted Synthesis of Enol Ether 114 and Derivatives 
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We believe this particular deprotection condition triggers a fast tert-butyl cation 
dissociation and transfer to the emerged enolate (cf. Scheme 3.10 for a mechanistic 
rationale). Inspired by accounts reporting [2,3]-Wittig rearrangement catalyzed by 
secondary amines,205 we attempted to react 189 with stoichiometric pyrrolidine, to achieve 
both oxa-6π electrocylization catalysis and formation of an electron-rich enamine 
substituted lactone. Unfortunately, this strategy proved unfruitful, and decomposition of 
the starting material took place. 
Scheme 3.10 Mechanistic Rationale for TMSOTf Deprotection of Ester 189 
 
 
Having synthesized an electron rich enol ether substituted lactone 114b, a remaining aim 
was to access an electron poor enol ether substituted lactone to react in normal demand 
Diels-Alder with 2H-pyran 115. By heating 189 in acetic anhydride with a catalytic amount 
of bismuth (III) triflate, we obtained acetate enol ether 114c in good yield (Scheme 3.11). 
NOESY NMR experiments were used to assign configuration of the enol acetate, wherein 
the acetate group was found to reside on the same side as the propenyl side chain. 
Mechanistically, we propose a first acetal formation would take place in the presence of 
Bi(III) and acetic anhydride. Upon loss of one acetate group, an intermediate oxonium 
would be generated and could adopt two conformations (Scheme 3.11, oxonium structure 
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A and B). Considering the propenyl side-chain may adopt an out-of-plane conformation, 
an unfavored allylic strain may destabilize conformation B over A, which would account 
for the fixed geometry observed in the final product 114c. 
Scheme 3.11 Synthesis of Enol Acetate Substituted Lactone 114c: Mechanistic and Stereochemical 
Rationale 
 
 
3.4 Studies toward a Biomimetic, Formal [4+2] Cycloaddition 
3.4.1 Ketene/2H-Pyran Coupling Attempts 
With our primary goal to access both electron rich and electron poor lactone 
dienophiles fulfilled, investigating the reactivity of diene 115 and ketene precursor 122 or 
enol ethers 114b,c became a primary focus. 
 We suspected that activating the carboxylic acid substituted lactone 122 directly 
instead of going through the acyl chloride may alleviate issues encountered during our 
ketene model studies with pyran 115 (i.e. direct 2H-pyran acylation,Chapter 2, Section 
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2.4.1, Scheme 2.22). First, lactone 122 was activated using Mukaiyama’s reagent 194206,207 
(Scheme 3.12 (A)), which is known to perform well in the activation of carboxylic acids 
in a range of reactions, including ketene generation.208,209 Unfortunately, at room 
temperature, decomposition of both the 2H-pyran and lactone 122 were observed.  
 We sought to invoke the stepwise route involving in situ formation of a ketene 
enolate from 122, which may further react with dienal 115’ (Chapter 2, Section 2.2.2, 
Scheme 2.8). In the presence of CDI as a carboxylate activator and with a catalytic amount 
of NHC 195,105 a successful combination in stepwise annulation,210 we were disappointed 
to observe decomposition of both partners 122 and 115 (Scheme 3.12 (B)). An identical 
result was obtained when attempting to generate a more reactive anhydride ester from 122 
that could be deprotonated and trapped as a ketene enolate with benzotetramisole catalyst 
196 109 (Scheme 3.12 (B)). Of note, the lactone 122 was difficult to dissolve in solvents 
compatible with ketene formation (e.g. non nucleophilic, polar, aprotic solvents such as 
CH2Cl2, THF), minimizing the efficiency of these reactions. 
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Scheme 3.12 Coupling Studies between 2H-Pyran 115 and Ketene Precursor 122 
 
 
3.4.2 Enol-Substituted Lactone as Dienophile: Concerted and Stepwise Approaches to 
Swerilactones A and B Core 
Given the challenges encountered during our proposed ketene [4+2] cycloaddition, 
the exploration of the biomimetic formal Diels-Alder approach with lactone dienophile 114 
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and derivatives was pursued (Chapter 2, Section 2.2). In comparison with the tert-butyl 
enol ether 114b, the synthesized enol acetate 114c offered the greatest versatility, as it 
could intervene in all normal demand cycloaddition, radical cation Diels-Alder annulation, 
and stepwise aldol reaction toward the swerilactone A and B core.  
For example, we hoped the electron-withdrawing character of the enol acetate 114c 
in comparison to tert-butyl enol ether 114b could be an advantage and enhance reactivity. 
Heating a mixture of 2H-pyran 115 with 114c in toluene, no cycloadduct was isolated; 114 
c was fully recovered and 115 decomposed over the course of the reaction (Scheme 
3.13(A)) as assessed by crude 1H NMR analysis. It was then envisioned to use a radical 
cation cyclization promoted by photocatalyst 170, which we had shown could occur 
between pyran 115 as a diene and an easily oxidizable dienophile (Chapter 2, Section 
2.4.3, Scheme 2.32). With these conditions, the recovery of enol acetate 114c and the 
simultaneous degradation of 115 was observed (Scheme 3.13(B)). The lack of reactivity 
of 114c in the generation of a radical cation may be due to its relatively lower electron 
density compared to other dienophiles, which may translate into a higher oxidation 
potential, out of the redox potential range for triphenylpyrylium tetrafluoroborate (Eox= 
2V). We plan to test these conditions using the more electron rich and potentially easier to 
oxidize tert-butyl enol ether 114b. 
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Scheme 3.13 Diels-Alder Cycloaddition Studies between 2H-Pyran 115 and Enol Acetate 114c 
 
 
 The prospect of employing enol acetate 114c in a more controlled reactivity pattern 
arose from numerous reported examples addressing aldol coupling of enol acetates with 
aldehydes. This type of transformation was shown to proceed via Lewis acid catalysis211–
215 or under basic conditions,216,217 by unmasking the enolate anion from the enol acetate 
and creating C-C bonds. By targeting the addition of the in situ formed enolate 114 from 
114c to the dienal 115’, we may access an aldol reaction to adduct 121’ as a first key C-C 
forming step en route to the swerilactone A and B core (Scheme 3.14). This strategy would 
overlap with the proposed biosynthesis for swerilactones A and related natural products 
(Chapter 2, Section 2.1.2, Scheme 2.1). 
The mild Lewis acid Sc(OTf)3 was introduced in catalytic amount to a mixture of 
114c and 115:115’ (Scheme 3.14 (A)). In this case, we recovered starting enol acetate 114c 
without detecting the desired product. We switched to basic conditions, adding K2CO3 in 
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excess to a mixture of 114c and 155’ in methanol, warming the temperature from 0 ˚C to 
40 ˚ C in order to increase the conversion of 114c. The unexpected acetal containing lactone 
structure 197 was generated as the major product (Scheme 3.14 (B)). Efforts to reproduce 
the synthesis of 197 were met with limited success and consequently this compound could 
only be characterized by 1H NMR. 
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Scheme 3.14 Stepwise Coupling Studies between Dienal 115’ and Enol Acetate 114c 
 
 
Two mechanistic rationales for the formation of this product are outlined in Scheme 
3.15. We postulate the in situ generated methoxide adds to the aldehyde moiety of 115’, 
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creating hemiacetal anion 198 (Scheme 3.15(A)). This intermediate could further add into 
the conjugated system of 114c, and upon E1/CB elimination of the acetate group from 
structure 199, acetal product 197 would emerge. Alternatively, in the presence of potassium 
methoxide, in situ deprotection of 114c to 114’ could be induced (Scheme 3.15(B)). This 
enolate may react in an aldol fashion with 115’, generating a hydroxyl anion 197’, which 
upon hydroxide elimination and methoxide addition would generate lactone acetal 197. 
Formation of this unwanted side-product may be avoided by conducting the aldol 
reaction with a stronger base in non-nucleophilic, aprotic solvents such as THF or CH2Cl2. 
It nonetheless constitutes a proof of concept that dienal 115’ can undergo nucleophilic 
attack into its aldehyde moiety. 
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Scheme 3.15 Mechanistic Proposals toward Acetal 197 
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3.4.3 Proposal toward the Synthesis of Swerilactone A and B Core Structures 
With the syntheses of two key building blocks 115 and 114b/114c achieved, we 
propose to test their coupling through different pathways. Probing the feasibility of the 
aldol pathway between 115’ and 114c would first require investigating the nucleophilic 
addition of a simple enolate, for example with the enolate derived from ethyl acetate. In 
the case this step was successful and produced an aldol adduct, we plan on testing the 
reactivity of the aldol pathway with 114c by employing basic or Lewis acid conditions 
(Scheme 3.16). The feasibility of this step, which forms the sterically congested aldol 
product 121’ remains an open question. Literature precedents regarding the formation of 
stereogenic centers via aldol reaction are focused on Mukayama Aldol with reactive silyl 
enol ethers218–220 and enamine-based transformations using organocatalysis.221–223 If the 
aldol adduct 121’ is produced, perhaps the process could be made stereoselective by 
employing a combination of chiral ligands and Lewis acid metals. This intermediate 121’ 
may be deprotonated and trigger a series of C-C bond forming steps (as we initially outlined 
in Chapter 2, Section 2.2.1, Scheme 2.4), via oxa-Michael addition and final vinylogous 
Aldol reaction. 
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Scheme 3.16 Proposed Route toward Swerilactone A and B Core via Aldol Reaction of 114c and 115’ 
 
 
 Alternatively, we propose the exploration of the radical cation cycloaddition 
pathway from tert-butyl enol ether 114b with triphenylpyrylium tetrafluoroborate 170 or 
with stronger chemical oxidants such as CAN or Mn(OAc)3 (Scheme 3.17). Use of enal 
substrates 194 and 195 (Scheme 3.8) in related experiments may also be possible. 
Scheme 3.17 Proposed Route toward Swerilactone A Core: Radical Cation Cycloaddition of 114b 
and 115 
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3.5 Proposal toward the Synthesis of Related Swerilactone Natural Products 
During the course of our studies in this family of natural products, we remained 
interested in targeting other members, such as (+)-sweriledugenin A (100). We 
hypothesized this compound could arise from a biomimetic cascade between two 
molecules of gentiogenal (200) in their iminium and enamine form (see Scheme 3.18 for a 
proposed forward startegy and potential catalysts). Enamine-iminium cascades have been 
applied in many elegant biomimetic approaches to natural products224–227 and we 
envisioned a similar concept could be applied toward (+)-sweriledugenin A (100). 
Scheme 3.18 Proposal toward (+)-Sweriledugenin via Enamine/Iminium Cascade 
 
 
 Mechanistically, we hoped the in situ generation of enamine 200a and iminium 
200b (Scheme 3.19) would trigger a vinylogous Michael addition to C-C linked pseudo-
dimer 201. This intermediate could undergo retro oxa-6π to yield oxatriene 202., which 
may be suited for a vinylogous Michael addition, affording the iminium-containing ring 
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system 203. Iminium-enamine equilibration may then occur, forming 204. Upon 
hydrolysis to intermediate 205, an aldol reaction could generate 206. Further hydrolysis 
to 207 followed by isomerization of the enal system and intramolecular nucleophilic 
attack would afford the lactol-containing (+)- sweriledugenin (100). 
Scheme 3.19 Enamine/Iminium Cascade: Mechanistic Proposal 
 
 
 
 In that regard, we have conducted preliminary studies targeting gentiogenal (200). 
In collaboration with Tim Harig (REU program, undergraduate student), we showed that 
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the commercially available compound gentiopicrin (208) could undergo glycosidic 
cleavage to the O-methyl protected gentiopicrin aglycon 209 (Scheme 3.20 (A)). This 
protected compound was then found to rearrange to gentiogenal (200) with a combination 
of MgI2 and TFA, in low yield, thereby mimicking the known biosynthetic transformation 
of gentiopicrin (208) by the enzyme β-glucosidase to gentiogenal (200).228,229 We have 
considered a mechanistic rationale for this transformation to include dual activation of the 
terminal alkene with TFA and of the lactone moiety with MgI2 (Scheme 3.20 (B)). 
Protonation of pyran 209 could trigger acetal opening to oxonium 210. Upon loss of 
methanol, intermediate 211 may tautomerize to its enol form, which is poised for an ene 
reaction that would generate dienal 200’. Oxa-6π electrocyclization would follow, 
affording the desired gentiogenal (200). 
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Scheme 3.20 Elaboration of Gentiogenal (200): Dual Lewis and Brønsted Acid Activation of 
Gentiopicroside (207) 
 
 
 This route enabled a low-yielding synthesis of gentiogenal, and would not be 
practical for larger scale access. We have alternatively attempted to formylate the 2H-pyran 
substrate 115. Under typical formylation conditions, such as Vilsmeier-Haack, or by 
chlorinating or brominating 115, a strategy that could have paved the way for Pd(0)-
mediated carbonylation, we were unable to produce the desired gentiogenal natural product 
(200) (Scheme 3.21). The attempt to leverage the observed nucleophilicity of 115 at its γ-
position (Chapter 2, Section 2.4.1, Scheme 2.22) with 2,2,2-trifluoroethyl formate in the 
presence of acetic acid was equally unproductive. 
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Scheme 3.21 Attempted Formylation Experiments of 115 
 
 
 We propose to investigate alternative formylation conditions to effect the 
formation of gentiogenal (200). A Rieche formylation230 promoted with TiCl4 and 
dichloromethyl methyl ether could be attempted, although competing chelation to pyran 
115 and opening to its dienal may be an unproductive reaction pathway. In addition, ethyl 
orthoformate might potentially serve as a masked formylating agent in this 
transformation. Once gentiogenal is obtained, its reactivity in enamine-iminium catalysis 
would be assessed. 
 
3.6 Conclusion 
Throughout this work, we have presented our efforts to access the core structure of 
swerilactone A (98) and B (99) biomimetically via a formal Diels-Alder cycloaddition. We 
have successfully completed the synthesis of a sensitive acyclic precursor to the 2H-pyran 
diene 115 through Saucy-Marbet rearrangement of propargyl vinyl ether 152. We have 
  
147 
further investigated the reactivity of compound 115 in several cycloadditions, and have 
shown thermal normal demand and radical cation Diels-Alder cycloadditions were 
productive modes of reactivity, whereas inverse demand cycloaddition was unfruitful. 
Several enol ether substituted lactones 114b and 114c meant to participate as electron-
rich dienophiles were subsequently synthesized via stepwise cross-couplings of a β-
brominated sorbate derivative, and final lactonization was undertaken by Lewis acid 
catalyzed oxa-6π electrocyclization, a seldomly applied strategy to construct six-membered 
ring lactones. The successful synthesis of both 2H-pyran diene 115 and enol ether lactone 
dienophiles 114b-c enabled further studies toward their coupling. We targeted several 
pathways to assemble these two fragments, from normal demand to radical cation 
cycloaddition to stepwise aldol coupling. Even though we have not been able to bring these 
compounds together in a desired fashion thus far, we believe this work constitutes an 
advancement in understanding 2H-pyran reactivities, outside of their known [4+2] 
dimerization, and that our proposed routes could ultimately yield the core structure of 
swerilactones A and B. 
Finally, we have synthesized key intermediates such as gentiogenal toward the 
synthesis of the congener (+)-sweriledugenin A (100). We believe the proposed enamine-
iminium cascade has significant potential and if successful would generate interesting 
polycyclic structures.  
 
 
  
148 
3.7 Experimental Section 
General Information: 1H NMR spectra were recorded at 300, 400, or 500 MHz at ambient 
temperature with CDCl3, CD3OD, DMSO-d6 or benzene-d6 (Cambridge Isotope 
Laboratories, Inc.) as solvents. Data for 1H NMR are reported as follows: chemical shift, 
integration, multiplicity (br = broad, ovrlp = overlapping, s = singlet, d = doublet, t = triplet, 
q = quartet, m = multiplet) and coupling constants in Hz. 13C NMR spectra were recorded 
at 100.0, or 125 MHz at ambient temperature with the same solvents unless otherwise 
stated. Chemical shifts are reported in parts per million relative to the deuterated solvents. 
All 13C NMR spectra were recorded with complete proton decoupling. Infrared spectra 
were recorded on a Nicolet Nexus 670 FT-IR spectrophotometer. High-resolution mass 
spectra were obtained in the Boston University Chemical Instrumentation Center using a 
Waters Q-TOF API-US mass spectrometer. Melting points were recorded on a Mel-Temp 
apparatus (Laboratory Devices). Analytical LC-MS was performed on a Waters Acquity 
UPLC (Ultra Performance Liquid Chromatography (Waters MassLynx Version 4.1) with 
a Binary solvent manager, SQ mass spectrometer, Water 2996 PDA (PhotoDiode Array) 
detector, and ELSD (Evaporative Light Scattering Detector). An Acquity UPLC BEH C18 
1.7 μm column was used for analytical UPLC-MS. Optical rotations were recorded on an 
AUTOPOL III digital polarimeter at 589 nm, and specific rotations are given [α]D20 
(concentration in grams/100 mL solvent). SFC analysis of enantioenriched compounds was 
performed on a Berger SFC (Waters) System with a diode array detector using a SFC 
Chiralcel®OD-H (Chiral Technologies Inc., 100 × 4.6 mm I.D., 5μm) column. Preparative 
HPLC was performed on a Gilson PLC2020 using a Waters SunFire™ Prep C18 OBD™ 
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5μm 19X50 mm column. Analytical thin layer chromatography was performed using 0.25 
mm silica gel 60-F plates. Flash chromatography was performed using 200-400 mesh silica 
gel (Scientific Absorbents, Inc.). Yields refer to chromatographically and spectroscopically 
pure materials, unless otherwise stated. HPLC grade tetrahydrofuran, methylene chloride, 
diethyl ether, toluene, acetonitrile, and benzene were purchased from Fisher and VWR and 
were purified and dried by passing through a PURE SOLV® solvent purification system 
(Innovative Technology, Inc.). Other ACS grade solvents for chromatography were 
purchased from Fisher. Select photochemistry experiments were performed using a 
jacketed beaker covered in tape with spiralled blue LEDs strip (hν = 450 nm) on the inside 
walls. A flow of cold water was used to cool the beaker down upon irradiation. All other 
reactions were carried out in oven-dried glassware under an argon atmosphere unless 
otherwise noted. 
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N,N-diisopropyl sorbate amide 174b: prepared according to literature 
procedure.185 
 
PIP sorbate amide 174c: To a flame-dried 250 mL round bottom 
flask, sorbic acid (from Aldrich) (653.9 mg, 5.8 mmol, 1.1 equiv.) was dissolved in 
anhydrous CH2Cl2 (20.00 mL). DMF (581.2 mg, 8.0 mmol, 618 μL, 1.5 equiv.) was added 
and at 0 °C, oxalyl chloride (706.55 mg, 5.57 mmol, 477.40 μL, 1.05 equiv.) was 
introduced dropwise. After stirring at room temperature for 4 hours, a solution of PIP amine 
(722.0 mg, 5.3 mmol, 1 equiv.) and triethylamine (590.1 mg, 5.8 mmol, 808 μL, 1.1 equiv.) 
in CH2Cl2 (20.00 mL) was added dropwise at 0°C. 
Reaction was left to warm up overnight at room temperature, and then quenched with sat. 
NaHCO3 solution. The aqueous phase was extracted 3 times with CH2Cl2, dried over 
sodium sulfate, concentrated in vacuo to yield a dark oil. Purification on silica gel (gradient 
of EtOAc in hexanes 5%, 10%, 15%, 20%, 30%) afforded the desired product as an off-
white solid. Rf =0.12 (Hexanes/EtOAc 75:35, UV, KMnO4); Mp 110-111 ˚C; IR νmax 
(film):3313, 3058, 2978, 2933, 1660, 1539, 1432, 1346, 1258, 1150, 997, 787 cm-1; 1H 
NMR (400 MHz, CDCl3) 8.51 (m, 1H), 7.76 (br s, 1H), 7.71 (td, J = 7.6, 1.6 Hz, 1H), 
7.41 (d, J = 8.4 Hz, 1H), 7.19 (m, 1H), 7.16 (m, 1H), 6.18 (m, 1H), 6.06 (m, 1H), 5.9 (d, J 
= 14.8 Hz, 1H), 1.82 (d, J = 6.4 Hz, 3H), 1.79 (s, 6H); 13C NMR (101 MHz, CDCl3)  
  
151 
165.5, 164.6, 147.6, 140.2, 137.0, 136.8, 129.8, 123.2, 121.8, 119.5, 56.5, 27.6, 18.4; HR-
MS: m/z Calcd for [C14H18ON2+H]
+ 231.1497, found . 
 
8-Aminoquinoline sorbate amide 174d: To a flame-dried 100 
mL round bottom flask: sorbic acid (from Aldrich) (1.0 g, 9.1 mmol, 1.1 equiv.) was 
dissolved in CH2Cl2 (20 mL). DMF (912.5 mg, 12.5 mmol, 971 μL, 1.5 equiv.) was 
introduced and at 0 °C, oxalyl chloride (1.11 g, 8.7 mmol, 749 μL, 1.05 equiv.) was added 
dropwise. 
After stirring at room temperature for 4 hours, a solution of quinolin-8-amine (1.20 g, 8.3 
mmol, 1 equiv.) and triethylamine (926.1 mg, 9.2 mmol, 1.3 mL, 1.2 equiv.) in CH2Cl2 (20 
mL) was added dropwise at 0 °C. 
Reaction was left to warm up overnight at room temperature, and then quenched with sat. 
NaHCO3 solution. The aqueous phase was extracted 3 times with CH2Cl2, dried over 
sodium sulfate, concentrated in vacuo to yield a dark oil. 
Purification on silica gel (gradient of EtOAc in hexanes, 3%, 5%, 8%, 10%) yielded the 
desired as an off-white solid. Rf =0.24 (Hexanes/EtOAc 99:1, UV, KMnO4); Mp 113-115 
˚C; IR νmax (film):3348, 1677, 1640, 1527, 1486, 1425, 1385, 1337, 1141, 997 cm-1; 1H 
NMR (500 MHz, CDCl3) 9.86 (s, 1H), 8.87 (dd, J = 7.6, 1.4 Hz, 1H), 8.17 (dd, J = 8.3, 
1.7 Hz, 1H), 7.56 (t, J = 7.9 Hz, 1H), 7.50 (dd, J = 8.2, 1.4 Hz, 1H), 7.46 (dd, J = 8.3, 4.2 
Hz, 1H), 7.40 (dd, J = 14.9, 10.6 Hz, 1H), 6.32-6.25 (m, 1H), 6.20 (m, 1H), 6.15 (m, 1H), 
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1.89 (d, J = 6.2 Hz, 3H), 1.79 (s, 6H); 13C NMR (101 MHz, CDCl3)  164.6, 148.0, 142.3, 
138.5, 138.4, 136.3, 134.7, 129.8, 127.9, 127.5, 122.4, 121.5, 121.4, 116.6, 18.6; HR-MS: 
m/z Calcd for [C15H14ON2+H]
+ 239.1184, found 239.1184. 
 
C5-iodination product 177d: In a thick-wall microwave vial 
equipped with a stir bar under air: 8-aminoquinoline sorbate amide 174d (10 mg, 42.0 
μmol, 1 equiv.) was introduced, followed by Pd(OAc)2 (0.47 mg, 2.10 μmol, 5 mol%), NIS 
(11.33 mg, 50.4 μmol, 1.2 equiv.), p-TSA.H2O (3.99 mg, 21 μmol, 50 mol%). Dry toluene 
(600 μL) was added and the reaction was heated at 110 °C for 12 h. TLC (hexanes/EtOAc 
7:3, UV+KMnO4) showed incomplete conversion to an upper spot. The crude mixture was 
concentrated in vacuo and purified on silica gel (Hex/EtOAc 9:1 85:15, 4:1, 7:3) to afford 
the desired as a yellow solid (4.7 mg, 12.91 umol, 30%). Rf =0.45 (hexanes/EtOAc 9:1, 
UV, KMnO4); Mp 136-137 ˚ C; IR νmax (film):3340, 2959, 2924, 2869, 1679, 1516, 1473, 
1380, 1356, 1315, 1260, 1136, 980 cm-1; 1H NMR (500 MHz, CDCl3) 9.86 (br s, 1H) 
8.75 (dd, J = 4.4, 1.6 Hz, 1H), 8.59 (d, J = 8.0 Hz, 1H), 8.35 (dd, J = 8.8, 2.0 Hz, 1H), 8.06 
(d, J = 8.4 Hz, 1H), 7.52 (dd, J = 8.8, 4.0 Hz, 1H), 7.36 (dd, J = 14.8, 10.4 Hz, 1H), 6.22 
(m, 1H), 6.19 (m, 1H), 6.11 (d, J = 14.8 Hz, 1H), 1.89 (d, J = 6.0 Hz, 3H); 13C NMR (101 
MHz, CDCl3)  164.6, 148.6, 142.7, 140.7, 139.0 (2C overlap), 138.3, 135.5, 129.7, 129.5, 
123, 122, 118.0, 89.0, 18.7; HR-MS: m/z Calcd for [C15H13OIN2+H]
+ 365.0151, found 
365.0146. 
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Tert-butyl 3,3-dibromoacrylate 175. 
Preparation of pure, dehydrated tert-butyl glyoxylate: 
Di-tert-butyl tartrate was synthesized according to reported literature 
procedures.190,231  
The tert-butyl glyoxylate was synthesized using a modified literature procedure.190 
Di-tert-butyl tartrate (11.30 g, 43.1 mmol, 1 equiv.)190 was dissolved in methanol (220 
mL). Using an addition funnel, a solution of sodium metaperiodate (11.06 g, 51.7 mmol, 
1.2 equiv.) in water (80 mL) was added at 0 °C dropwise. After 3 hours, TLC showed 
complete conversion (hexanes/ethyl acetate 7/3, KMnO4). 
Et2O (200 mL) and H2O (100 mL) were added, the phases were separated and the water 
phase was extracted once with Et2O (100mL). The combined organic layers were dried 
over Na2SO4 and filtered. Concentration under cold conditions gave a crude mixture, still 
containing methanol, which is dried a second time using sodium sulfate, concentrated in 
vacuo with a room temperature water bath. It was then redissolved in ether (200 mL) 
transferred to a separatory funnel, and washed with a minimal amount of water (2x20 mL) 
to pull the remaining methanol out of the organic phase. The ether layer was dried again, 
concentrated under cold water bath to give a yellow crude oil. After concentration in a 100 
mL flask, the aldehyde was transferred in a Kugelrohr receiving flask, which was put under 
high vacuum at room temperature for 20 minutes, then cooled to -78 °C. 3 spatula portions 
of P2O5 were added at -78°C to control the exothermic dehydration reaction. The crude 
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mixture was then distilled under high vacuum using a Kugelrohr distillation apparatus (120 
°C, 50 rpm) to yield a clear oil, kept cold at -78 °C. 
Preparation of the gem-dibromoolefin 169 from tert-butyl glyoxylate 
To a flame-dried two-neck 1L flask equipped with a 125 mL addition funnel: 
carbon tetrabromide (57.08 g, 172.1 mmol, 2 equiv.) and zinc (0) (11.26 g, 172.1 mmol, 2 
equiv.) were added, the apparatus was purged with a vaccum/nitrogen cycle 3 times. before 
adding dry CH2Cl2 (300 mL). Triphenylphosphine (45.15 g, 172.1 mmol, 2 equiv.) was 
added into the addition funnel, and dissolved with CH2Cl2 (180 mL). 
At 0 °C, the homogenous solution of phosphine was added over 45 minutes. The reaction 
was stirred at room temperature for 20 minutes, turning yellow upon triphenylphosphine 
addition, and red-orange by the end of the addition. 
The aldehyde, kept at -78°C in its receiving flask from the distillation, was diluted with 
portions of dry CH2Cl2, transferred via cannula to the addition funnel, rinsed several times 
(total volume of CH2Cl2 300 mL). This cold solution of aldehyde was then added over 30 
minutes at 0°C into the reaction flask. The reaction was left to warm up to room 
temperature and stirred for 48 h. 
Hexanes was added to precipitate the phosphine oxide and the crude was filtered over 
celite, rinsing thoroughly the reddish slurp with hexanes, then ethyl acetate. Purification 
on silica gel (Hexanes/EtOAc 100:0, 99:1, 98:2) afforded the desired product as a yellow 
oil Rf =0.1 (Hexanes/EtOAc 99.5:0.5, UV, KMnO4); IR νmax (film):3053, 2978, 2930, 
1721, 1591, 1477, 1453, 1368, 1301, 1136, 972, 866, 849, 822, 756, 690 cm-1; 1H NMR 
(400 MHz, CDCl3) 6.8 (s, 1H), 1.5 (s, 9H); 13C NMR (126 MHz, CDCl3)  162.1, 129.6, 
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104.7, 82.2, 28.1; HR-MS: m/z Calcd for [C7H10O2Br2+H]
+ 284.9126, found no ionization 
for this compound. 
 
Tert-butyl bromosorbate 172: In a flame-dried, 500 mL 3-neck round 
bottom flask under nitrogen, Pd2dba3 (250.7 mg, 273.9 μmol, 3 mol%), P(2-Furyl)3 (423.8 
mg, 1.8 mmol, 20 mol%) and CuI (347.7 mg, 1.83 mmol, 20 mol%) were added, and flask 
was purged 3 times with a vacuum/nitrogen cycle. 
In a separate flame-dried 250 mL round bottom flask, tert-butyl 3,3-dibromoacrylate 175 
(2.61 g, 9.1 mmol, 1 equiv.) and tributyl-[(E)-prop-1-enyl]stannane193 (3.33 g, 10.0 mmol, 
1.1 equiv.) were introduced under argon. Rigorously degassed (via freeze-pump-thaw 
cycle 3 times) toluene (100 mL) was added under argon and the resulting diluted solution 
of starting materials were transferred to the main round bottom flask via cannula. 
The reaction was moved to an oil bath and heated at 90 °C for 4.5 hours, after which time 
a 1H NMR crude aliquot of the reaction showed complete conversion of the gem-dibromo 
olefin starting material (starting material and product have identical Rf in EtOAc/Hexanes 
eluent system). The crude reaction was quenched with 15% aqueous KF solution, extracted 
with EtOAc 3 times, washed with brine, dried over Na2SO4, and concentrated in vacuo. 
Purification on silica gel doped with 15% w/w solid KF (hexanes/EtOAc 100:0, 99:1, 98:2) 
afforded the desired product as a yellow oil (1.90 g, 7.69 mmol, .84%). 
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Rf =0.1 (Hexanes/EtOAc 99.5:0.5, UV, KMnO4); IR νmax (film):2977, 2933, 1719, 1476, 
1451, 1391, 1367, 1257, 1144, 952, 853 cm-1; 1H NMR (500 MHz, CDCl3) 6.52 (dq, J = 
14.0, 7.0 Hz 1H), 6.21 (s, 1H), 6.11 (dq, J = 14.0, 2.0 Hz 1H), 1.91 (dd, J = 7.0, 2.0 Hz 
1H), 1.51 (s, 9H); 13C NMR (126 MHz, CDCl3)  164.1, 138.4, 134.0, 130.6, 120.9, 81.1, 
28.2 (3C), 18.0; HR-MS: m/z Calcd for [C10H15O2Br+H]
+ 247.0334, found no ionization 
for this compound. 
 
Coupling product 180: In a flame-dried 250 mL Schlenk flask under  
nitrogen: tert-butyl bromosorbate 172 (1.53 g, 6.19 mmol, 1 equiv.), methyl 2-
tributylstannylprop-2-enoate 179196 (5.11 g, 13.62 mmol, 2.2 equiv.), palladium tetrakis 
(715.42 mg, 619.11 umol, 10 mol%) and copper iodide (884.32 mg, 4.64 mmol, 0.75 
equiv., previously dried under high vacuum with a heatgun) were dissolved in dry, 
degassed (freeze-pump-thaw cycle, 3x) DMF (70.00 mL). The flask was heated at 60 °C 
for 3h. Reaction was assessed complete by crude 1H NMR of an aliquot. 10% aqueous KF 
solution was added (50 mL) and the crude was diluted with ethyl acetate. The aqueous 
layer was extracted with EtOAc (50 mL x2), and the combined organic layers were washed 
with water (50 mL) to pull out most of the DMF. The organic layer was dried over sodium 
sulfate, concentrated in vacuo and dry loaded on silica gel (hexanes/EtOAc 99.5:0.5, 99:1, 
98:2, 97:3, 96:4, 95:5, 9:1, 85:15, 8:2, 7:3) to afford the desired as a viscous yellow oil. Rf 
= 0.18 (Hexanes/EtOAc 95:5, UV, KMnO4); IR νmax (film): 2978, 2952, 2854, 1727, 
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1705, 1638, 1589, 1437, 1392, 1366, 1291, 1237, 1138, 1040, 987, 965, 934, 877, 814 cm-
1; 1H NMR (500 MHz, CDCl3) 6.51 (d, J = 1.4 Hz, 1H), 6.22 (d, J = 14.0 Hz, 1H), 5.97 
(dq, J = 14.0, 6.5 Hz, 1H), 5.72 (s, 1H), 5.51 (d, J = 1.4 Hz, 1H), 3.74 (s, 2H), 1.82 (d, J = 
6.5 Hz, 3H); 13C NMR (126 MHz, CDCl3)  165.8, 165.5, 148.7, 137.5, 134.8, 132.8, 
127.2, 120.7, 80.4, 52.0, 28.0 (3C), 18.5; HR-MS: m/z Calcd for [C14H20O4+Na]
+ 
275.1259, found 275.1259. 
 
TFA deprotection of coupling product 180: In a 100 mL round bottom flask, acrylate 
180 (1.20 g, 4.76 mmol, 1 equiv.) was dissolved in CH2Cl2 (45.00 mL). At room 
temperature, trifluoroacetic acid (recent bottle, 1.63 g, 14.28 mmol, 1.09 mL, 3 equiv.) was 
added, and after 5 hours, TLC showed complete conversion (hexanes/EtOAc 3:7). The 
crude mixture was concentrated in vacuo, and TFA was azeotroped with toluene (3x) under 
vacuum. Crude 1H NMR showed complete conversion to a mixture of the opened 
carboxylic acid and closed lactone form. Purification on silica gel (hexanes/EtOAc 9:1, 
8:2, 7:3, 6:4, 1:1) afforded carboxylate 181 (228 mg, 1.16 mmol, 24%, upper spot, Rf = 
071, Hexanes/EtOAc 75:25, UV, KMnO4) and lactone 182 (313.0 mg, 1.6 mmol, 33%, 
lower spot) as yellow oils. Compound 181 (228 mg, 1.16 mmol, 1 equiv.) was further 
thermalized in toluene (20 mL) for 16 h. Concentration of the crude mixture in vacuo 
followed by silica gel purification (hexanes/EtOAc 9:1, 8:2, 7:3, 6:4, 1:1) afforded the 
lactonized product 182 (85 mg, 0.43 mmol, 37%). 
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Lactone 182: Rf =0.11 (Hexanes/EtOAc 75:25, UV, KMnO4); IR νmax 
(film): 2954, 2919, 2853, 1726, 1644, 1605, 1440, 1378, 1306, 1255, 1220, 1089, 970, 
873, 808 cm-1; 1H NMR (500 MHz, CDCl3) 6.29 – 6.15 (m, 2H), 5.93 – 5.89 (m, 1H), 
4.75 (dd, J = 11.5, 1.5 Hz, 1H), 4.45 (dd, J = 11.5, 4.2 Hz, 1H), 3.75 (s, 3H), 3.50 (dd, J = 
4.2, 1.5 Hz, 1H), 1.91 (d, J = 6.0 Hz, 3H); 13C NMR (126 MHz, CDCl3) 169.4, 164.2, 
149.8, 136.1, 129.5, 116.8, 67.9, 53.1, 40.4, 18.9 ; HR-MS: m/z Calcd for [C10H12O4+H]
+ 
197.0814, found 197.0815. 
 
Carboxylic acid substituted lactone 122: In a flame-dried thick wall 
microwave vial under argon, lactone 182 (33.5 mg, 170.7 μmol, 1 equiv.) was introduced. 
In the glove box, magnesium iodide (95.0 mg, 341.5 μmol, 2 equiv., new bottle kept inside 
the glovebox and covered in aluminum foil) was transferred into the vial. Dry toluene (1.5 
mL) was added, before an argon balloon was bubbled through the vial while sonicating the 
mixture simultaneously for 30 minutes, to ensure proper degassing and activation of the 
magnesium surface. The vial was then sealed and heated at 110 °C overnight, in the dark. 
TLC showed disappearance of starting material and base line spot (CH2Cl2/MeOH 95:5). 
The crude is quenched with 1M HCl, extracted with CH2Cl2 (3x), dried and concentrated 
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in vacuo. Crude 1H NMR showed complete conversion to the carboxylic acid. Purification 
on silica gel with first EtOAc/Hexanes (1:1 then 100:0), and then a gradient of MeOH in 
CH2Cl2 (from 5% to 20%) afforded the polar desired compound as a yellow viscous gum 
(12.0 mg, 65.9 μmol, 37%). Rf =0.1 (CH2Cl2/MeOH 95;5, UV, KMnO4); IR νmax (film): 
3427, 2930, 2856, 2252, 1696, 1641, 1593, 1411, 1381, 1282, 1244, 118, 1087, 966, 911, 
869 cm-1; 1H NMR (500 MHz, CDCl3) 6.26-6.24 (m, 2H), 5.93 (s, 1H), 4.80 (d, J = 11.5 
Hz, 1H), 4.47 (dd, J = 11.5, 4.0 Hz, 1H), 3.53 (d, J = 4.0 Hz, 1H), 1.93 (d, J = 5.0 Hz, 3H); 
13C NMR (126 MHz, CDCl3) 166.6, 157.4, 154.6, 136.9, 129.9, 114.5, 69.9, 42.6, 18.9; 
HR-MS: m/z Calcd for [C9H10O4+H]
+ 183.0579, found 183.0582. 
 
Cross-coupling of stannylated alcohol 183 and bromo sorbate 172: In a flame-dried 
microwave vial under argon: palladium tetrakis (21.04 mg, 18.21 μmol, 10 mol%) was 
introduced inside the glovebox followed by tert-butyl bromosorbate 172 (45.00 mg, 182.09 
μmol, 1 equiv.) and stannane 183196 (126.41 mg, 364.18 μmol, 2 equiv.). Flask was purged 
with argon, before copper iodide (previously dried under high vacuum with a heat gun, 
26.01 mg, 136.57 μmol) was added. Dry DMF (2.00 mL) was transferd via syringe and the 
whole mixture was degassed by bubbling argon through for 15 minutes. The reaction was 
stirred at 40 °C overnight under argon, after which time TLC showed complete conversion 
(hexanes/EtOAc 85:15, UV, KMnO4). The crude was quenched with 15% KF aqueous 
solution, extracted with EtOAc (2x), dried over sodium sulfate, filtered and concentrated 
in vacuo. Purification on a mixture of 15% w/w ground KF on SiO2 (gradient of 
hexanes/EtOAc 98:2, 95:5, 90:10, 88:12, 86:14, 85:15) enabled isolation of the desired 
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alcohol 184 (14.00 mg, 62.42 μmol, 34%) and the undesired lactonization product 185 
(12.00 mg, 79.9 μmol, 43%) as yellow oils. 
 
Alcohol coupling product 184: Rf =0.28 (Hexanes/EtOAc 4:1, UV, 
KMnO4); IR νmax (film):3431, 2977, 2931, 2857, 1692, 1592, 1452, 1367, 1293, 1247, 
1137, 1053, 966 cm-1; 1H NMR (400 MHz, CDCl3) 6.01 (app d, J = 15.6 Hz, 1H), 5.99 
(dq, J = 15.6, 6.4 Hz, 1H), 5.69 (s, 1H), 5.37 (d, J = 1.2 Hz, 1H), 4.88 (d, J = 1.2 Hz, 1H), 
4.20 (d, J = 5.6 Hz, 2H), 3.47 (t, J = 5.6 Hz, 1H), 1.81 (dd, J = 6.4, 0.8 Hz, 3H), 1.45 (s, 
9H); 13C NMR (101 MHz, CDCl3)  153.3, 145.6, 135.3, 132.1, 120, 114.6, 80.9, 66.7, 
28.1 (3C), 18.5; HR-MS: [M+H]+ calculated for [C13H20O3+H]
+ 225.1491, found 
225.1509. 
 
Lactonized coupling product 185: Rf =0.24 (Hexanes/EtOAc 4:1, UV, 
KMnO4); IR νmax (film): 3436, 2974, 2931, 2876, 1706, 1648, 1578, 1395, 1291, 1221, 
1054, 966, 933, 872 cm-1; 1H NMR (500 MHz, CDCl3) 6.37 (dq, J = 15.6, 6.7 Hz, 1H), 
6.17 (ddd, J = 15.6, 1.5, 0.9 Hz, 1H), 5.94 (d, J = 0.9 Hz, 1H), 5.58 (dd, J = 1.0, 2.0 Hz, 
1H), 5.45 (dd, J = 1.0, 3.0 Hz, 1H), 4.85 (m, 2H), 1.92 (dd, J = 6.7, 1.5 Hz, 1H); 13C NMR 
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(126 MHz, CDCl3)  164.9, 150.1, 136.3, 135.6, 125.2, 117.62, 113.3, 70.9, 19.0; HR-MS: 
[M+H]+ calculated for [C9H10O2+H]
+ 151.0759, found 151.0753. 
 
Diethyl acetal protected coupling product 191: In a 50 mL Schlenk 
flask under nitrogen, palladium tetrakis (79.49 mg, 68.79 μmol, 10 mol%) was introduced 
in the glove box, followed by copper iodide (98.26 mg, 515.92 μmol, 0.75 equiv.) 
(previously dried under high vacuum with a heat gun), tert-butyl bromosorbate 172 (170.00 
mg, 687.90 μmol, 1 equiv.) and stannane 190196 (557.47 mg, 1.38 mmol, 2 equiv.). Dry, 
distilled DMF (8.00 mL) was degassed via freeze-pump-thaw cycle (3x), and then 
cannulated to the Schlenk flask containing the catalysts and substrates. The flask was 
transferred to an oil bath heated at 60 °C, and stirred 12 hours. Crude 1H NMR of an aliquot 
showed complete conversion. Reaction was quenched with 15% KF aqueous solution, 
extracted with EtOAc (2x), dried over sodium sulfate, filtered and concentrated in vacuo. 
Purification on a mixture of 15% w/w ground KF on SiO2 (hexanes/EtOAc 99:1, 98:2, 
95:5, 92:8, 90:10, 88:12, 86:14, 85:15) yielded the desired as a yellow oil (103.50 mg, 350 
μmol, 50%). Rf =0.30 (Hexanes/EtOAc 95:5, UV, KMnO4); IR νmax (film): 2975, 2929, 
1708, 1588, 1448, 1367, 1290, 1135, 1061, 966, 870 cm-1; 1H NMR (400 MHz, CDCl3) 
6.10-6.13 (m, 2H), 5.67 (d, J = 1.0 Hz, 1H), 5.61 (s, 1H), 5.05 (s, 1H), 4.98 (d, J = 1.0 Hz, 
1H), 3.70 (q, J = 7.0 Hz, 2H), 3.53 (q, J = 7.0 Hz, 2H), 1.81 (d, J = 7.5 Hz, 3H), 1.44 (s, 
9H), 1.18 (t, J = 7.0 Hz, 6H).; 13C NMR (126 MHz, CDCl3)  165.5, 152.9, 142.9, 135.2, 
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133.3, 118.8, 115.0, 79.9, 79.7, 62.7 (2C), 28.14 (3C), 18.5, 15.1 (2C); HR-MS: [M+H]+ 
calculated for [C17H28O4+H]
+ 297.2066, found no ionization for this compound. 
Acetal lactone 192: In a 10 ml round bottom flask, diethyl acetal 
product 191 (15.10 mg, 50.94 μmol, 1 equiv.) was dissolved in CH2Cl2 (1 mL). At 0°C, 
trifluoroacetic acid (11.6 mg, 102 μmol, 2 equiv.) was introduced via syringe. The reaction 
immediately turned yellow. TLC (hex/EtOAc) shows complete conversion. The reaction 
was directly concentrated in vacuo, and reconcentrated with toluene (2x) to azeotrope TFA. 
Crude was purified on silica gel (Hexanes/EtOAc 9:1, 8:2, 7:3, 6:4) to isolate desired as a 
clear oil (7.4 mg, 38.10 μmol, 74%). Rf = 0.22 (Hexanes/EtOAc 85:15, UV, KMnO4); IR 
νmax (film): 2978, 2930, 1716, 1648, 1581, 1443, 1395, 1225, 1103, 973, 872, 618 cm-1; 
1H NMR (500 MHz, CDCl3) 6.39 (dq, J = 15.5, 6.5 Hz, 1H), 6.19 39 (d, J = 15.5 Hz, 
1H), 5.94 (s, 1H), 5.70 (s, 1H), 5.64 (s, 1H), 5.63 (s, 1H), 4.00 (dq, J = 9.5, 7.0 Hz, 1H), 
3.71 (dq, J = 9.5, 7.0 Hz, 1H), 1.91 (dd, J = 6.5, 1.7 Hz, 3H), 1.25 (t, J = 7.0 Hz, 3H).; 13C 
NMR (126 MHz, CDCl3)  163.7, 148.0, 136.6, 136.3, 125.7, 120.0, 112.8, 101.8, 64.9, 
19.0, 15.0; HR-MS: [M+H]+ calculated for [C11H14O3+H]
+ 195.1021, found 195.1030. 
 
Acrylate 193: In a 50 mL round bottom flask, diethyl acetal 191 
(383.30 mg, 1.29 mmol, 1 equiv.) was dissolved in THF (10.00 mL). At room temperature, 
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HCl (1 M, 1.94 mL, 1.5 equiv.) was added, and reaction was heated at 40 °C. After 3 hours 
TLC (hex/EtOAc 9:1) showed complete conversion to a lower spot. The reaction was 
quenched with water, extracted with EtOAc (3x), dried over Na2SO4 and concentrated in 
vacuo. The yellow crude oil was purified on silica gel (Hex/EtOAc, 99:1, 98:2, 96:4 
plateau, 95:5, 9:1, 8:2) to afford the desired compound as a yellow oil (172 mg, 774 μmol, 
60%). Rf = 0.39 (Hexanes/EtOAc 9:1, UV, KMnO4); IR νmax (film): 2976, 2921, 2853, 
1705, 1638, 1589, 1456, 1368, 1290, 1260, 1120, 1140, 964, 873 cm-1; 1H NMR (400 
MHz, CDCl3) 9.59 (s, 1H), 6.32 (d, J = 0.8 Hz, 1H),), 6.23 (d, J = 15.5 Hz, 1H), 6.14 (d, 
J = 0.8 Hz, 1H), 5.85 (dq, J = 15.5, 8.5 Hz, 1H), 5.80 (s, 1H), 1.80 (dq, J = 8.5, 1.5 Hz, 
3H), 1.41 (s, 9H); 13C NMR (126 MHz, CDCl3) 191.2, 165.2, 146.7, 135.0, 133.1, 132.4, 
121.1, 110.0, 80.5, 28.1 (3C), 18.5; HR-MS: [M+H]+ calculated for [C13H18O3+H]
+ 
283.1334, found 283.1346. 
 
Tert-butyl enol 114b: In a flamed dried 10 mL Schlenk flask under argon: 
acrylate 189 (20.0 mg, 90 μmol, 1 equiv.) was dissolved in CH2Cl2 (1.5 mL). The reaction 
was cooled down to -78 °C. After 5 minutes, trimethylsilyl triflate (new bottle, freshly 
distilled using a Hickman apparatus under high vacuum at room temperature) (4.00 mg, 
18.00 μmol, 3.26 μL, 0.2 equiv.) was added at -78 °C. Upon addition of TMSOTf, the 
reaction turned immediately yellow. TLC (Hex/EtOAc 8:2) after 15 minutes shows 
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incomplete conversion. Reaction was transferred to an ice bath, and stirred 15 minutes at 
0 °C. TLC (Hex/EtOAc 6:4) after 15 minutes indicated complete conversion. The reaction 
was quenched with aqueous saturated NH4Cl, extracted with CH2Cl2 (15 mLx2), dried and 
concentrated in vacuo. Crude 1H NMR showed clean conversion to tert-butyl enol ether 
cyclized product 114b as a single enol ether isomer (stereochemistry not assigned) (crude 
yield 10.6 mg, 47.7 μmol, 53%). This compound degrades upon silica gel purification, thus 
it is better used as is. Efforts to reproduce the synthesis of 114b were met with limited 
success and consequently this compound could only be characterized by 1H NMR. Rf = 
0.10 (Hexanes/EtOAc 4:1, UV, KMnO4); 1H NMR (400 MHz, CDCl3) 6.88 (d, J = 1.5 
Hz, 1H), 6.37 – 6.23 (m, 1H), 6.08 (dq, J = 19.5, 1.5 Hz, 1H), 5.66 (s, 1H), 4.98 (m, 2H), 
1.90 (dd, J = 6.5, 1.5 Hz, 3H) 1.36 (s, 9H). 
 
Enol acetate 114c: In a flame-dried thick wall microwave vial under argon: 
tert-butyl bromosorbate 172 (37.0 mg, 166.5 μmol, 1 equiv.) was dissolved in acetic 
anhydride (2 mL). Bismuth triflate (5.5 mg, 8.3 μmol, 5 mol%) was then added. The 
reaction turned immediately dark orange and was heated at 60 °C. After 2 h, full conversion 
by TLC (Hex/EtOAc 95:5, eluted twice to see separation of starting material from product) 
was observed. The reaction was diluted with EtOAc and water, transferred to a separatory 
funnel and the organic phase was collected. The aqueous phase was extracted once with 
EtOAc. Washing of the organic phase with aqueous NaHCO3 (2x) removed most of the 
  
165 
acetic acid. Drying and concentration of the organic phase afforded a crude oil that 
solidified to needles upon standing. Purification on SiO2 (hex/EtOAc 99:1, 98:2, 96:4, 95:5, 
9:1, 8;2, 7;3, 1;1, 4:6, 0:100) yielded a major compound as an off-white solid (12.00 mg, 
57.6 μmol, 71%). Rf =0.37 (Hexanes/EtOAc 3:2, UV, KMnO4); Mp 118-119 ˚C; IR νmax 
(film):3091, 2957, 2936, 2919, 2867, 1704, 1629, 1391, 1360, 1225. 1024, 897 cm-1; 1H 
NMR (400 MHz, CDCl3) 7.50 (ap s, 1H), 6.47 (dq overlap, J = 15.5, 6.5 Hz, 1H), 6.33 
(s, 1H), 6.25 (ap d, J = 15.5 Hz, 1H), 4.83 (s, 2H), 2.08 (s, 3H), 1.94 (dd, J = 6.5, 1.5 Hz, 
3H); 13C NMR (100 MHz, CDCl3)  170.4, 161.9, 152.5, 151.4, 136.8, 124.2, 113.6, 109.2, 
59.5, 20.8, 19.1; HR-MS: [M+H]+ calculated for [C13H18O3+H]
+ 209.0814, found 
209.0816. 
 
Acetal lactone 197: In a thick wall microwave vial under argon, enol 
acetate 114c (12.0 mg, 57.6 μmol, 1 equiv.) and 2H-pyran 115 (11.5 mg, 69.2 μmol, 2 
equiv.) were dissolved in MeOH (700 μL). At 0 °C, potassium carbonate (9.6 mg, 69.2 
μmol, 1 equiv.) was introduced at once. Reaction turned from a white slurry to yellow 
immediately. The reaction was left to stir at room temperature for 30 minutes, after which 
time TLC (hex/EtOAc 6:4, UV, KMnO4) showed minor conversion. 
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One more equivalent of potassium carbonate was added. Reaction was heated at 40 °C 
for 1 hour. It was quenched with ammonium chloride, diluted with CH2Cl2 and extracted 
(2x) with CH2Cl2. After concentration, crude
 1H NMR showed cleavage of the acetate, 
and the presence of a few products. Silica gel purification (9:1, 8:2, 7:2, 6:4, 1:1) afforded 
the acetal lactone 197 as a clear oil (3.4 mg, 9.8 μmol, 17%). Efforts to reproduce the 
synthesis of 197 were met with limited success and consequently this compound could 
only be characterized by 1H NMR. Rf =0.15 (Hexanes/EtOAc 3:2, UV, KMnO4); 1H 
NMR (500 MHz, CDCl3) 7.39 (s, 1H), 6.48 (dq, J = 15, 6.5 Hz, 1H), 6.33 (dq, J = 15.5, 
1.0 Hz, 1H), 6.33 (m, 1H), 6.22 (s, 1H), 6.22 (m, 1H), 5.78 (s, 1H), 4.40 (t, J = 6.0 Hz, 
2H), 4.15 (s, 2H), 3.36 (s, 3H), 2.57-2.52 (m, 2H), 1.94 (dd, J = 6.5, 1.5 Hz, 3H), 1.90 (d, 
J = 5 Hz, 3H). 
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